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Abstract 
The circulating renin-angiotensin system (RAS) plays an important role in the 
regulation of blood pressure, fluid and electrolyte homeostasis. Recently, a shift in 
emphasis from circulating RAS to local RAS in regulating individual tissue functions 
via an autocrine or paracrine manner has been focused in tissues including the brain, 
i t 
heart and kidney. , 
In the present study, the expression and localization of major components of 
RAS have been demonstrated in the rat pancreas using molecular biological and 
immunohistochemical approaches. The expression of mRNA for angiotensinogen, renin � 
and angiotensin receptor subtypes, namely ATu, ATib and AT2 were demonstrated in the 
rat pancreas. In line with the mRNA expression, angiotensinogen protein was also 
demonstrated to be expressed. In addition, angiotensinogen protein and renin protein 
were localized specifically to the epithelia and endothelia of pancreatic ducts and blood 
vessels respectively. These data support the existence of a local RAS in the rat pancreas, 
which may play a role in the regulation of pancreatic blood flow and ductal secretion. 
The pancreatic RAS was further demonstrated to be subjected the regulation by 
chronic hypoxia and by experimental pancreatitis. Chronic hypoxia activates the local 
RAS in the pancreas in both neonatal and mature rats. Briefly, angiotensinogen mRNA 
and protein expression were increased by chronic hypoxia. However, a differential 
effect was exhibited in the expression of angiotensin receptors. For AT! receptor, a 
significant change in mRNA expression for ATib receptor subtype in neonatal rats was 
found while a significant increase in mRNA expression for ATia receptor subtype was 
- i 
found in mature rats. For AT2 receptor, a marked increase in expression was found in 
both neonatal and mature rats. 
Interestingly, the activation of pancreatic RAS by chronic hypoxia, with 
particular reference to the up-regulation of AT2 receptor, was found to be reversible after 
returning to the normoxic condition for about two weeks onwards. 
In experimental pancreatitis, it also activates the pancreatic RAS components in 
a similar pattem as observed in chronic hypoxia. “ 
In summary, the present study supports the existence of an intrinsic RAS in the 
rat pancreas, which is subject to activation by chronic hypoxia and pancreatitis. These 
changes in pancreatic RAS in response to chronic hypoxia and pancreatitis could be 





有重要作用的一種生理系統 °從最近的科學研究指出’除了循環賢素 -血管緊張 
素系統外，局部賢素 -血管緊張素系統亦存在於大白鼠腦部、心赋和賢赋等組 
織 °它們利用旁分泌和自分泌形式來調節各組織之獨特功能。 
































一 英中譯名對照 一 “ 
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angiotensin receptor 血管緊張素受體 
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Chapter 1 Introduction 
1.1 General review of pancreas 
The pancreas of the rat is an elongated, pinkish diffuse organ that lies behind the 
stomach, extending from the duodenum to the spleen. It can be divided anatomically 
into three parts: head, body and tail region. The broad head of the pancreas lies 
within the loop formed by the duodenum; the slender body extends extensively 
toward the spleen; and the tail is short and bluntly rounded attached to the spleen. 
The pancreas is composed of both an exocrine and an endocnne portion, which 
produce pancreatic enzymes and hormones respectively. 
1.1.1 Exocrine pancreas � 
The exocrine pancreas is composed of numerous single layer acinar pyramidal 
cells, they are arranged in small, sac-like clusters called acma. These cells are 
actively involved m the production of the enzymatic components of the pancreatic 
juice; their cytoplasm is filled with an elaborate system ofendoplasmic reticulum and 
Golgi apparatus. There are also a few centroacmar cells lining the lumen of the 
acmus. These cells, in contrast lack an elaborate endoplasmic reticulum and Golgi 
apparatus. The acini are connected by small intercalated ducts. They will then empty 
into somewhat larger intralobular ducts. All o f the intracellular ducts ofapart icular 
lobule then drain into the extralobular ducts, which in tum empty into larger ducts. 
These larger ducts finally converge mto a main collectmg duct that enters the 
duodenum along the common bile duct. 
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The aqueous component ofpancreaticjuice is a bicarbonate rich fluid required 
for optimal enzyme activity when the acidic chyme empties into the duodenum. 
These secretions originate from the columnar epithelial pancreatic duct cells. 
Pancreatic juice is nearly isotonic to the plasma at all flow rates. The Na+ and lC 
concentrations of pancreaticjuice are the same as those in plasma. 
The pancreas secretes a variety of digestive enzymes that are important for the 
digestion of all the major classes offoodstuffs. The first major class of enzyme is the 
proteolytic enzymes for the breakdown of large proteins and polypeptides into small 
I* 
peptides and amino acids. These can be divided into endopeptidases and 
rf 
exopeptidases. Trypsin, chymotrypsin and elastase are the endopeptidases for the 
cleavage of certain amino acid linkage in the interior of proteins and peptides, 
whereas carboxypeptidase and aminopeptidase are exopeptidases liberating terminal 
% 
amino acids with free carboxyl groups from the ends of proteins and peptides. 
The second class of pancreatic enzyme is lipolytic enzymes mcluding 
triacylglycerol hydrolase, phospholipase and cholesterol esterase. They are the only 
enzymes of the gastrointestinal system capable of digesting triacylglycerol fats mto 
monoglycerides and free fatty acids. 
The pancreas also secretes a-amviase, as likely as salivary amylase, it cleaves 
starch polysaccharides into oligosaccharides. Other digestive enzymes secreted by 
pancreas are ribonuclease and deoxyribonucleases, which are the nucleic acids-
digesting enzymes. 
Pancreatic secretion is under neural and hormonal control. For neural control, 
stimulation of the parasympathetic fibers in the vagus nerve enhances secretion of 
pancreatic juice, whereas activation of sympathetic fibers inhibits pancreatic 
• 2 
secretion. For the hormonal control, secretin and cholecystokinin (CCK), which are 
secreted from the duodenal mucosa during digestion, stimulate the bicarbonate and 
enzyme secretion respectively. 
1.1.2 Endocrine pancreas 
The islets of Langerhans are the functional units of the endocrine pancreas and 
they account for 1-2% of the total mass of pancreas. The islets of Langerhans are 
discrete clusters of cells that contain from a few hundreds to several thousand 
i t 
hormone-secreting endocrine cells. Each islet is fully supplied with blood vessels, so 
that hormones can be secreted directly into blood vessels. Anatomically, each islet is 
surrounded by a connective tissue sheath for the separation of islets from the acinar 
cells. 
% 
Islets are composed of four major hormone-producing cell types: glucagon-
secreting alpha cells, insulin-secreting beta cells, somatostain-secreting delta cells and 
pancreatic polypeptide-secretmg F cells. Among of all, alpha cells and beta cells are 
the most numerous, comprising about 20-25% and 60-70% o f t h e endocnne cells 
respectively. 
Insulin is a peptide hormone that consists of an A-chain and a B-chain held 
together by two disulfide bonds. Secretion of insulm is in response to various stimuli, 
the most important physiological stimulus is a rise in plasma glucose concentration, 
which occurs mostly after a meal. The overall effect ofinsulin is to increase glucose 
uptake and use by tissues thus to lower blood glucose in order to maintain a constant 
blood glucose concentration. After that, several amino acids, fatty acids and 
gastrointestinal hormones are also known to stimulate insulin secretion. 
. 3 
Glucagon is a single-chain polypeptide consisting o f29 amino acids. In contrast 
to insulin, glucagon is secreted when there is a reduction in blood glucose 
concentration. Therefore, the circulating glucagon concentration is the highest when 
fasting. In addition to glucose, amino acids and autonomic nervous system also 
regulate glucagon secretion. Somatostatin inhibits both insulin and glucagon 
secretion but the exact role has not been fully established. 
I* 
ff 1.2 The renin-angiotensin system (RAS) 
The work on renin-angtioensin system started in 1898. It was found that 
injection of kidney extracts subcutaneously or intravenously could increase blood 
pressure of the recipients. The researchers named this substance 'renin' and regarded � 
it as an internal secretion ofkidney [Tigerstedt and Bergman, 1898]. Later, a series of 
experiments were carried out to confirm this finding and to investigate this system 
deeply. It was identified that Tenin' is an enzyme which produced a pressor 
substance in vitro when incubated with blood plasma [Braun-Menendez et al., 1940]. 
Shortly after, both the enzyme substrate and the pressor substance were identified as 
angiotensinogen and angiotensin respectively. 
At the present time, the prevailing view holds that the circulating RAS is an 
endocrine system for the production of angiotensin in plasma through the systemic 
circulation [Cat et al., 1970; Vane, 1974]. This concept can be summarized as 
follows: angiotensinogen, which is produced from the liver, generates angiotensin I 
by the action of renin released from the kidney. On passage through the pulmonary 
vasculature, angiotensin I is converted by angiotensin converting enzyme (ACE) to 
4 
angiotensin II, which is conveyed via arterial blood to the angiotensin receptors in 
peripheral tissues to give out physiological functions (Figure 1-1). 
1.2.1 Aiigiotensinogen 
Angiotensinogen is the only precursor of the angiotensin peptides and limits the 
enzymatic reaction of renin. It is a 55- to 60-kDa glycoprotein mainly synthesized in 
the liver [Page et al, 1941] and is nominally 477 amino acids with a signal sequence 
o f 2 4 amino acids in rodents [Ohkubo et al., 1983; Clouston et al., 1988]. 
t* 
Angiotensinogen secreted is introduced to the circulatory system to become 
ff 
associated with the ai-globulin, a2-gl0bulin or aIbumm fraction ofplasma depending 
on the species [Plentl et aI., 19431. The plasma angiotensinogen concentration vanes 
from species to species and is about 0.8-1 ^iM in man, 0.3-0.5 ^iM in rat and 0.5-0.7 
% 
d^VI in rabbit [Reid et al., 1978|. Its concentration increased after treatment of 
adrenocorticotrophic hormone (ACTH). estrogen, and adrenal cortical hormones 
[Reid et al., 1973; Helmer and Gnffith, 1952] and decreased after hypatectomy, 
adrenalectomy and hypophysectomy |Hasegawa et al., 1973; Reid et al., 1973J. 
Two different forms of angiotensinogen were released from isolated heptocytes 
as examined by isoelectric focusing in rat plasma [Murakami et al., 1984]. The 
heterogeneity of angiotensinogen can be explained by several potential sites for N_ 
linked gIycosylation ( at Asn-23, Asn-271, and Asn-295 in rat) [Hilgenfeldt and 
Hackenthal, 1982; Tewsbury, 1983; Sernia and Mowchanuk, 1983]. 
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Figure 1-1: Biochemistry o f t h e major components ofrenin-angiotensin system. 
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Normally, angiotensinogen circulates as a low-molecular-weight form, which is the 
major component of plasma angiotensinogen. 
However, the larger form ofangiotensinogen exists at higher plasma level during 
the last trimester of pregnancy and is occasionally the predominant form in the plasma 
ofhypertensive pregnant women. (Tewsbury and Dart, 1982]. 
1.2.2 Renin 
Renin is an aspartyl protease which cleaves angiotensinogen to form angiotensin 
1» 
I. The nucleotide sequence of the genome of renin has 10 exons in human and those 
ff 
of rat and mouse has nine [Hardman et al., 1984; Hobart et al., 1984]. A high degree 
of sequence identity was found among the three renal renins. 
There are two forms of renin found, namely the active and inactive form. 
Inactive renins were found in plasma, amniotic fluid and kidney [Lumbers, 1971; 
Nielsen and Poulsen, 1988; Day and Luetscher, 1975]. These inactive renins are 
M> 
termed 'prorenin' or ‘preprorenirf. In rats and rabbits, both active and inactive renins 
are released from renal cortical slices |Misono et al., 1976|. It is suggested that 
inactive renin was activated by trypsin or acidification. Moreover, renin-activating 
enzyme, cathepsin G, found in platelets and neutrophils, and a renin-bound protem 
has been found in renal tubules of rat, suggesting for the interconversion of inactive 
renin and active renin [Dzau, 1984a; Ikemoto et al., 1982]. 
The afferent arteriolarjuxtaglomerular cells of kidney are the sites of renin gene 
production in the endocrine system |Cook, 1971]. The preprorenin synthesized in 
cytoplasm is rapidly internalized into rough endoplasmic reticulum and hydrolyzed by 
the signal protease to produce prorenin. The prorenin is then converted to an active 
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form in the Golgi apparatus and secreted by exocytosis under cellular regulation [Pratt 
etal., 1983]. 
Renin gene is found in mouse submandibular glands but not in rat suggesting the 
expression of renin gene is tissue-specific [Morris et al., 1980�. 
1.2.3 Angiotensin I 
Angiotensin I is a decappeptide which is cleaved from the N-terminus of 
angiotensinogen by renin. Ln rat, it attaches to the N-terminus by the Leu-Leu bond, 
1» 
whereas by Leu-Val bond in human [Tevvksbury et al., 1981]. It has been considered 
产 
as inactive precursor of angiotensin II. 
1.2.4 Angiotensin converting enzyme (ACE) 
Like renin, ACE is a dipeptidyl carboxyl peptidase which is a membrane-bound 
ectoenzyme. It converts angiotensin I by cleavage ofHis-Leu dipeptidyl residue from 
its carboxyl terminal COOH" to form the biologically active peptide, angiotensin II. 
Lung is the major site for synthesis and conversion taking place [Ng and Vane., 
1967]. This is accounted by the great surface area of the pulmonary capilIanes 
allowing sufficient speed of conversion and making it accessible of circulatmg 
macromolecules . The other sites exist in the kidney, liver, and systemic vascular 
beds. As ACE is a membrane-bound peptidase with an anchor peptide in the 
membrane and a zinc ectoenzyme on the luminal surface of the membrane, ACE 
conversion of angiotensin II occurs extracellularly in the lungs. 
Apart from Phe-His bond, ACE cleaves a number of dipeptide bonds and some 
tripeptide bonds. Thus, it also cleaves bradykinin, metenkephalin, substance P and 
-. 8 
luteinizing hormone releasing hormone. 
1.2.5 Angiotensin II 
Angiotensin II is a biologically active component of the renin-angiotensin 
system. It exhibits a wide spectrum of biological actions including body fluid 
balance, cardiovascular homeostasis and growth promotion in relation to angiogenesis 
and cardiotrophy [Allen et al., 1988|. 
Apart from its well known pressor effect, angiotensin II also plays an important 
i t 
role in the regulation of body fluid homeostasis. Renin is released in response to a 
ff 
decrease in blood volume, then leads to an immediate increase in plasma angiotensin 
II [Tobian et al., 1959; Skinner et al.. 1963J. Angiotensin II induces thirst and sodium 
appetite and increases intestinal absorption of water and sodium ions. It also reduces 
water and sodium loss through the kidney by decreasing the glomerular filtration rate 
and tubular reabsorption [Kobayashi and Takei, 1982]. 
ft» 
According to some findings, angiotensin II stimulates transepithelial fluid and 
electrolyte transport in rat [Levens et aL 1981,1986; Bolten et al., 1975]; stimulates 
medull£uy catecholamine secretion | Peach, 1971]; modulates the releases of several 
pituitary hormones including luteinizing hormone, prolactin, ACTH, growth hormone 
and vasopressin [Steele et al., 1982a. l9S2b, 1983]; stimulates prostagulandin release 
and affects intracellular calcium and phospahatidyl inositol phosphate metabolism 
[Smith et al., 1984]. 
All the l^st-acting with shorl duration by angiotensin II’ suggesting that it is the 
hormone responds to emergent changes in the internal or external environment and 
initiates physiological reactions to restore the status. 
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1.2.6 Angiotensin receptors 
Angiotensin receptors are divided into two types according to their affinity for 
different antagonists: Type 1 receptors (ATi) which have affinity to Dup753 
(losartan) and type 2 receptors (AT2) which have affinity to PD123177 and 
CGP42112A [Chiu et al., 1989; Bumpus et al., 1991]. 
Type 1 receptor can be further sub-divided into two subtypes (ATu and ATib) 
according to their signal transduction systems; one coupled with Gq-type GTP-
binding protein and the other coupled with Gi-type, but type 2 receptors do not couple 
I I 
with any GTP-binding protein [Catt and Abbott, 1991]. 
产 
The ATi receptor of rat consists of 359 amino acids residues and contains three 
potential N-glycosylation sites; one in the hydrophobic N-terminal extracellular 
region and the other two in the third extracellular loop. The two ATi receptors have 
about 96% sequence homology at the nucleotide levels. The ATia receptor is 
localized on rat chromosome 17 and ATib on rat chromosome 2 [Lewis et al., 1993]. 
These subtypes are expressed in various target tissues with different proportions 
[Kakar et al., 1992a; Ye and Hearly, 1992]. Although some studies found no 
differences in ligand binding affinity between the AT^ and ATib subtypes [Sasamura 
et al., 1992; Chiu et al., 1993], others have suggested moderate differences in ligand 
affmity between these two receptor subtypes. It was observed that the affinity of 
angiotensin I for the rat ATib subtypes was 10-fold less than that at the ATia subtypes, 
whilst 3 to 4-fold higher affmity for angiotensin II at ATib subtypes compared to the 
ATia subtypes [Kakar et al., 1992b]. 
Following the pharmacological characterization of two major angiotensin II 
receptor subtypes, there was considerable interest in determining the physiological 
“. ‘ 1 0 
functions they mediated. As considerable proprietary research had ah*eady been 
conducted on the efficacy of losartan as an antihypertensive agent, it was quickly 
revealed that ATi was the one that mediated the vasoconstrictor actions of angiotensin 
II. In addition, most of the major known functions of angiotensin II, such as 
stimulation of aldosterone and norepinephrine release, and pressor and tachycardic 
response could be inhibited by the ATi selective anatgonist losartan, but not by AT2 
selective anatgonist PD123177. Thus, it was suggested that all of the major known 




The AT2 receptor has also been expression-cloned from the cDNA library of the 
rat pheochromocytoma cell line [Kambayashi et al., 1993] and of whole rat fetuses 
[Mukouyama et aL, 1993]. The cDNA encodes 363-amino acid protein which has 
approximately 30% sequence identity with that of ATi receptor. By Northem blot 
analysis, it showed that the receptor is more abundantly expressed in fetuses than in 
adults, AT2 seem to play a role in growth and development. 
For the localization of angiotensin receptors, ATi receptors are mainly localized 
predominately in the vascular smooth muscle, whereas the AT2 receptors are 
concentrated in the adrenal medullar and uterus. However, both types ofreceptors are 
found in the adrenal cortex, kidney and brain [Timmeraians et al., 1991]. 
“. ‘ 1 1 
1.3 Tissue RAS 
Recent findings suggesting the classic concept of circulating RAS requires 
revision [Fei et al., 1981; Campbell, 1985]. The levels of angiotensin I and II are 
much higher in venous blood than that in arterial blood as there is efficient conversion 
of angiotensin I to angiotensin II in peripheral tissues. In addition, their levels are so 
high that the rate of generation of angiotensins I and II in blood is not fast enough. 
Taken together, these data suggesting peripheral tissues instead ofcirculating RAS are 
the major sites of production of angiotensins [Campbell, 1985]. According to this 
I I 
revised concept, the primary function of circulating RAS is not systemic delivery of 
angiotensin II to tissues, but rather the delivery of angiotensinogen and renin to 
tissues for the generation of angiotensin II locally. Thus, the plasma levels of 
angiotensins largely represent a spillover from the tissue sites of production. That 
plasma angiotensins predominately result from the action of kidney-derived renin on 
plasma angiotensinogen is shown by the fall in plasma angiotensin levels that follow 
nephrectomy [Catt et al., 1967，1971; Semple et al., 1976; Waite, 1973], and by the 
hypotensive effect of anti-angiotensinogen antibodies when injected into either 
sodium-repleted or sodium-depleted rats [Grades et al., 1982]. 
There are increasing numbers of studies suggesting the existence of local 
generation of angiotensin II within tissues, which is independent, in whole or in part, 
of the circulating RAS. These tissues included brain [Okamura et al., 1981; Fishman 
et al., 1981; Printz et al., 1982; hiagami, 1982; Ganten et al., 1983], kidney [Morris 
and Johnson, 1976; Mendelsohn, 1982; Celio et al.，1981; Namse et al., 1982; 
Taugner et al., 1982; Kawamura et al., 1985], adrenal [Aguilera et al., 1981;Ganten et 
. a l . , 1983; Okamura et al., 1984], testis [Pandey et al., 1984a] and arterial wall 
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[Swales, 1979; Swales et al., 1983]. ki these tissues, angiotensinogen mRNA and/or 
renin mRNA are detected, providing strong evidence for their local synthesis in vivo 
(Figure 1-2). 
1.3.1 Alternative angiotensin generating enzymes 
Other than renin, there are enzymes that may participate in the production of 
angiotensin from angiotensinogen in extrarenal tissues. Chromatographic separations 
of renin-like enzymes have yielded fractions containing non-renin neutral or acidic 
I t 
proteases capable of generating angiotensin I from angiotensinogen [Dzau et al., 
1984b]. These enzymes include cathepsin [Dorer et al., 1978; Hackenthal et al., 
1978], pepsin [Franze de Fernandez et al., 1965] and other aspartyl proteases [Haas et 
al., 1984; Husain et al., 1984; Haas et al., 1985] and renin-like enzymes [Haber and 
Slater, 1977; Menard et al., 1980; Dzau et al., 1980; Deboben et aL, 1983]. Their 
physiological role and specificity are not known and thought to be released from 
subcellular components (e.g. lysosomes) and usually function at an acidic pH [Orci et 
al.，1986]. 
hi addition to well known angiotensin converting enzyme, tonin [Boucher et al., 
1977], cathepsin G [Tonnesen et al., 1982], trypsin [Arakawa et al., 1980a] and 
kalliUa-ein [Maruta and Arakawa, 1983] have also been shown to convert angiotensin 
I to angiotensin II in vitro. More recently, a chromostastin-sensitive angiotensin II 
generating enzyme (CAGE) has been reported in aortic tissues of dog, monkey and 
human. It disturbs predominately in the adventitia [Okunish et al., 1987] which is 
important for angiotensin II in the adventitial-outer medial area where there is 
sympathetic innervation. 
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Tissue Angiotensinogen Rerdn 
Protein mRNA Protein mRNA 
Adrenal cortex + + + + 
Adrenal meduUa + 
Brain + + + + 
Endothelium + + + + 
Gut :+ + 
Heart + + + “ + 
Kidney + + “ + + 
Liver + + + 
Lung + + + 
Ovary + + + + 
Pituitary + + + 
Placenta + + + 
Salivary gland + + + + 
Spleen + ‘ + 
Testis + + + + 
Thyroid + 
Uterus + + + 
Vascular smooth + + + + 
muscle 
Figure 1-2 : Presence of renin and angiotensinogen protein and its mRNAs in 
various tissues. [CampbeU 1987] 
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Another class of non-renin angiotensinogenases is the angiotensin II generating 
enzyme which cleaves angiotensin II directly from angiotensinogen. Tonin, cathepsin 
G, elastase and tissue plasminogen activator (t-PA) [Tang et al., 1989] have been 
shown to possess this capability. These enzymes cleave angiotensinogen between 
Phe-His residues and yielding angiotensin II directly. This cleavage is highly 
selective, since angiotensin I is not generated by any ofthese enzymes (Figure 1-3). 
1.3.2 Integration of circulating RAS and local RAS 
I I 
The generation of angiotensin II within a tissue may be either intracellular or 
产 
extracellular. Lntracellular generation of angiotensin may be resulted from the 
cleavage ofeither locally synthesized angiotensinogen or angiotensinogen taken up by 
the cell; renin and angiotensin-converting enzyme responsible for cleavage may be 
either cellular enzyme or enzyme that taken up by the cell. Angiotensin or enzyme 
taken up by a cell may be plasma-derived or may have been secreted into the 
interstitial space by neighboring cells. Plasma-derived and locally synthesized 
angiotensinogen may coexist in the interstitial space, where they may be cleaved by 
either plasma-derived renin or locally synthesized renin or renin-like enzyme, to 
produce angiotensin [Campbell, 1987] (Figure 1-4). For example, both testes and 
pituitary contain no detectable angiotensinogen mRNA [Campbell and Habener, 
1986] but there is evidence for synthesis of renin and local production of angiotensin 
[Field et al., 1984; Pandy et al., 1984b; Namse et al., 1981; Steel et al., 1982]. 
Presumably, plasma is the source of angiotensinogen for local angiotensin synthesis 
in these two tissues. 
( .,• 
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Figure 1-3 : Multiple pathways of angiotensin production. 
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Figure 1-4: Proposed integration ofcirculating renin-angiotensin system and 
local renin-angiotensin system. 
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Given that locally production of angiotensin may be derived from the interaction 
of plasma-derived renin and angiotensinogen, and/or the interaction of locally 
synthesized components, the relative contribution of these two systems is an 
important question to local angiotensin production. For those areas of the brain and 
spinal cord within the blood-brain barrier, locally synthesized components o f R A S are 
the major source of angiotensin. However, this question remains unanswered in other 
tissues. 
I t 
1.3.3 Function of tissue RAS 
The concept of the tissue RAS is that there is a separate synthetic mechanism for 
the production of angiotensin II to meet the function for the individual tissue. The 
close proximity of cells in tissue allows angiotensin produced by the cells to act in a 
paracrine or autocrine fashion [Campbell, 1987; Phillips, 1987; Dzau et al., 1988a]. 
For the concept ofparacrine concept, one cell produces angiontensin II and delivers to 
the neighboring target effector cells which bind and respond to the angiotensin II. For 
the advantage of proximity, angiotensin II is not degraded and responses can occur 
rapidly as cells are close together. In case of autocrine concept, the cell produces 
angiotensin II，releases it, and this acts back via its membrane receptors onto the same 
cell in order to exert its actions. Intracrine function refers to the intracellular effect of 
angiotensin II and these may be related to the possibility ofangiotensin II receptors in 
the nucleus regulating DNA pre-transcriptional events, as well as mRNA transcription 
of growth factors and the cell regulatory protein. Since the structure of the trans-
membrane seven domain ATi receptor [Sasaki et al., 1991; Murphy 1991’ 1992] is 
known, it is hypothesized that some of the internal loops may serve as receptor sites 
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for intracellular angiotensin 11. Therefore, tissue RAS provides a more tonic and 
specifically local influence in those tissues where they exist: for example, the 
regulation of vascular tone, or renal, cardiac, adrenal or intestinal function. That is 
totally different from circulating RAS which provides an extremely rapid and efficient 
homeostasis response to acute changes in blood pressure and fluid and electrolyte 
status. 
The ubiquity of the tissue RAS raises the possibility that they may share a 
common function such as the regulation oftissue blood flow. There is spme evidence 
that angiotensin II is angiogenic [LeNoble et al., 1991] and a role in forming new 
blood vessels in rapidly growing tissue, particularly in ovaries, uterus and placenta. 
However, there is little evidence that the tissue systems have a local vascular 
regulatory function. Instead, available data indicated that locally produced 
angiotensin II is generally concerned with the unique functions of each tissue in 
which it is formed [Ganong, 1994]. „ 
1.3.4 Tissue RAS in pancreas 
The existence oftissue RAS in pancreas has been studied based on the detection 
o fmRNA for rat angiotensinogen and renin. Previous study showed that no signal of 
angiotensinogen mRNA was detected in the rat pancreas by means of Northern 
blotting technique [Campbell and Habener, 1987]. More recently, dog pancreas has 
becn studied and angiotensinogen mRNA has been expressed using a human 
angiotensinogen cDNA as a hybridization probe. It was detected that the amount of 
angiotensinogen mRNA is about 2% of that in the liver. In addition, angiotensin II 
level was measured and found to be in moderately high quantities (524+74 finoly'g 
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tissue for Ang II). This level is much higher than blood level, which may imply that 
there is endogenous synthesis of angiotensins. However, neither angiotensin I nor 
renin activity was detected, suggesting that angiotensin II is synthesized through an 
alternative remn-independent pathway [Chappel et al., 1991]. 
However, recent studies from our laboratory have shown that angiotensin II 
receptor subtypes ATi and AT2 are present in the pancreas from the rat and the mouse 
[Leung et al., 1997a，1998]. The immunoreactivity o f A T i and AT2 receptors were 
observed predominately in the endothelia of blood vessels and epithelia of the 
1» 
pancreatic ductal system. Consistent with the previous report that binding sites for 
ff 
angiotensin II have been identified in the rat pancreas using radioreceptor binding 
assay and autoradiography [Ghiani and Masini, 1995], it was suggested that a tissue 
RAS may be in the rat pancreas which may play a role in regulating the pancreatic 
blood flow and functional ductal anion secretion [Leung et al., 1997a]. 
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1.4 Hypoxia and RAS 
1.4.1 General review of hypoxia 
Hypoxia is defined as a deficiency of oxygen at the tissue level. There are many 
potential causes ofhypoxia, and they can be classified into four general categories: (1) 
hypoxic hypoxia, in which arterial oxygen alveolar gas pressure (P02) is reduced; (2) 
anemic hypoxia, in which the arterial P02 is normal, but the total oxygen content of 
the blood is reduced; (3) ischemic hypoxia, in which blood flow to the tissues is too 
low or even loss of oxygen supply; and (4) histotoxic hypoxia, in which the quantity 
of oxygen reaching the tissue is normal but the cell is unable to utilize the oxygen 
because of some toxic agent or disorder ofthe cell itself. 
1.4.2 Effect ofhypoxia on RAS 
Kidney 
Hypoxia is known to interfere with the water and electrolyte balance of the 
organism leading to changes in urinary electrolytes [Janoski et al., 1991]. These 
influences result from a complex interaction of the renin-angiotensin-aldosterone 
system (RAAS) and renin system. The influence ofhypoxia on the activity ofRAAS 
has been investigated in numbers of studies and found that hypoxia leads an decrease 
in aldostreone secretion [Sutton et al., 1977; Heyes et al., 1982; Colice and Ramirez, 
1985; Lawerence et al., 1990]. 
Also, the renin system appears to be modulated by the oxygen tension. Several 
reports support an increase in plasma renin activity after inspiratory hypoxia [Mattioli 
et al., 1975; Milledge et al., 1983; Oparil et al., 1988]. Both acute hypoxic stress and 
venous hypoxia stimulate renin secretion and renin gene expression in vivo. 
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However, it does not change renin expression and renin gene expression in vitro in 
primary cultures of renal juxtaglomerular cells [Ritthaler et al., 1997] or in isolated 
perfUsed kidneys of the dog [Spath et al., 1971]. The findings suggested that the 
stimulation of renin system by hypoxia is an indirect rather than a direct effect. The 
mediation of stimulatory effect of hypoxia on the renin system could be the 
involvement of sympathoadrenergic activation as increased in plasma levels of 




The local ACE expression was determined in hypoxia-induced heart. There is a 
differential effect on right and left ventricular ACE expression. Right ventricular 
ACE activity was increased by hypoxia while that was decreased in left ventricular 
ACE activity [Morrell et al., 1997]. 
Increased right ventricular ACE activity was positively correlated with right 
ventricular hypertrophy [Abraham et al., 1971; Rabinovitch et al., 1979]. The 
hypertrophy reflects an attempt to maintain right ventricular output. It was found that 
the increased ACE activity was highly localized, involving the visceral pericardium 
and areas of myocardial fibrosis. One possible effect of locally increased ACE 
expression in the hypertrophied ventricle would be to increase the local production of 
angiotensin II from angiotensin I [Schunkert et al., 1990]. Angiotensin II is known to 
cause hypertrophy of cardiac myocytes in cultured cells [Aceto and Baker, 1990]，a 
process mediated through the ATi receptor [Miyata and Haneda, 1994]. One other 
important action of ACE is the degradation of bradykinin. to the hypertrophied and 
pressure-overloaded left ventricle, a majority of the antihypertrophic effects of ACE 
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inhibitors are thought to be due to the potentiation of bradykinin [Linz and 
Sch6Ucenes, 1992]. In the pathogenesis of hypoxia-induced right ventricular 
hypertrophy, increased local angiotensin II production by locally up-regulated ACE 
expression may be more important than enhanced degradation ofbradykinin. 
Unlike the right ventricle, there was reduced ACE activity in the left ventricle. 
This can be accounted for by the reduced number of lef t ventricular capillaries which 
expressed ACE. Reduced left ventricular capillary ACE activity may serve to limit 
mycarodial oxygen consumption during prolonged hypoxia, analogous to the down-
regulation of P-adrenergic receptors in the chronically hypoxic rat heart [Kacimi et 
al., 1992]. “ 
Presumably, the regulation of ACE expression during chronic hypoxia is under 
different control mechanisms in the left and right ventricles. There should be the 
involvement of local factors in the regulation of ACE expression, rather than 
circulating factors, which would be expected to affect both ventricles similarly. 
Lung 
The pulmonary vasculature responds to chronic hypoxia by vasoconstriction and 
structural re-modeling [Riley, 1991]. The puhnonary arteries of hypoxic rats show 
progressive hypertrophy of the muscular coat in the arterial media and an abnormal 
extension of smooth muscle into normally thin-walled puhnonary arterioles, with 
consequent narrowing of the vessel lumen. These changes are thought to be related to 
RAS. 
In support of this view, it has been shown that whole lung ACE activity is 
reduced by chronic exposure to hypoxia [Kentere et al., 1981; Kay et aL, 1985; 
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Jederlinic et al., 1988] while the expression of angiotensin II receptors in lung 
membranes is increased. Competition with specific Angiotensin II antagonists 
demonstrated that ATi is the predominant subtype in both normal and hypoxic lung. 
It was suggested that angiotensin II, via the AT! receptor, has a role in the early 
pathogenesis of hypoxia-induced puhnonary hypertension in the rat [Morrell et al., 
1995a;Zhao etaL, 1996b]. 
i> 
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1.5 Pancreatitis and RAS 
1.5.1 General review of pancreatitis 
Lnflammation of the pancreas, ahnost always associated with acinar cell injury, 
is termed pancreatitis. Clinically and histologically speaking, pancreatitis occurs as a 
spectrum both in duration and in severity. Pancreatitis can be divided into acute 
pancreatitis and chronic pancreatitis. 
Acute pancreatitis is characterized by the rapid onset of abdominal pain and 
variable abdominal tenderness resulting from the enzymatic necrosis and 
I I inflammation of the pancreas. Typically, there is an elevation of pancreatic enzymes 
ff 
in blood and urine. The release of pancreatic lipases causes fat necrosis in and about 
pancreas, in even more severe case, there is damage to the vasculature with resulting 
hemorrhage into the parenchyma of this organ. There are four basic alterations for the 
morphological changes of acute pancreatitis. They are: (1) edema, (2) acinar cell 
necrosis, (3) hemorrhage and fat necrosis and (4) inflammation. The gross 
appearance of the most severe form of acute pancreatitis is characterized by areas of 
blue-black hemorrhage interspersed with areas of gray-white necrotic softening, 
sprinkled with foci of yellow-white, chalky necrosis. 
There are a variety of predisposing conditions for acute pancreatitis which have 
been identified and they can be classified into four categories: metabolic, mechanical, 
vascular and infectious. Among all, the most common are alcoholism and gallstones, 
which together are responsible for approximately 80% of the cases. Acute 
pancreatitis has a high mortality rate, patients with alcohol-induced acute pancreatitis 
are particularly at risk [Lankish et al., 1999]. 
Chronic pancreatitis is characterized by repeated bouts of mild to moderate 
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pancreatic inflammation, with continued loss of pancreatic parenchyma and 
replacement by fibrous tissue. 
1.5.2 Association of pancreatic RAS and hypoxia-induced pancreatic injury 
Alcohol-induced reduction of pancreatic blood flow has been suggested to play a 
role in the pathogenesis of pancreatic injury associated with alcohol abuse [Friedman 
et al., 1983; Horowitz and Myers, 1982; Widdison et al., 1992; Dib et al., 1993]. This 
hypothesis fits well with the concept of ischemia as a major determinant in the 
pathogenesis and evolution of acute pancreatitis [Klar et al., 1990]. Alcohol 
ff 
administration was associated with decreased pancreatic hemoglobin oxygen 
saturation despite stable hemoglobin content and systemic cardiorespiratory 
parameters. This constellation can be explained as the relative ischemia produced by 
reduced capillary flow and hypoxia resulting from relatively increased oxygen 
extraction. 
There are other mechanisms by which alcohol might cause pancreatic hypoxia. 
Since the rat pancreas is actively involved in ethanol metabolism [Estival et al., 1981; 
Solomon et al., 1974], pancreatic oxygen demand may increase after ethanol 
administration. Others have suggested that ethanol may depress pancreatic capillary 
blood flow by causing edema of the acinar cell, with consequent capillary 
compression [Dib et al., 1993]. 
In conclusion, a raised blood ethanol level was associated with the acutely 
decreased hemoglobin oxygen saturation in the pancreas. This provoked hypoxia 
provides a possible mechanism by which alcohol contributes to pancreatic injury 
[Foitzik et al., 1995]. 
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After that, it was found that there was an induction ofangiotensinogen following 
acute inflammation [Kageama et al., 1985]. The regulation ofpancreatic RAS may be 
involved in pancreatic injury. 
1.6 Aim of study 
Existence of a local RAS in the rat pancreas 
Recent findings on the localization of angiotensin II and its receptor subtypes 
11 
ATi and AT2 suggest the possibility of a local renin-angiotensin system ^flAS) in the 
/r 
rat pancreas. It may play a role in regulating pancreatic functions such as pancreatic 
microcirculation and ductal anion secretion. Therefore, the first aim of the present 
study was to demonstrate the existence of an intrinsic RAS in the rat pancreas. This 
was achieved by the study on the expression ofmajor RAS components at gene level 
and protein level using reverse-transcription polymerase chain reaction (RT-PCR) and 
Western blot analysis respectively. In addition, localization of key components 
indispensable for an intrinsic RAS such as angiotensinogen and renin was performed 
using unmunohistochemistry. 
Regulated expression of pancreatic RAS by chronic hypoxia 
It has been shown that the expression of local RAS was regulated by hypoxia in 
a number of tissues and it may, in tum, lead to hypoxia induced tissue injury. For 
example, the up-regulation expression of angiotensin receptors and angiotensin 
converting enzyme has been demonstrated in chronically hypoxic rat heart and lung, 
indicating that activation of RAS by hypoxia should be important for the 
• . 2 7 
physiological and pathophydiological changes of these tissue functions. Accordingly, 
the second aim of the present study was to examine the expression changes of RAS 
components such as angiotensinogen and angiotensin receptor subtypes ATi and AT2 
by chronic hypoxic treatment at the gene level using RT-PCR and at the protein level 
using Westem blot analysis. In addition, the altered expression and localization by 
chronic hypoxia were investigated using unmunohistochemistry. 
Developmental changes of pancreatic RAS expression by chronic hypoxia 
It is known that chronic hypoxia decreases the young brain size more prominent 
than that in adult brain suggesting that the influence during early development may 
not only in physiological adaptation but also in the developmental process. It is of 
interest to elucidate the effect of chronic hypoxia on the expression of RAS by 
chronic hypoxia during the developmental stages of rats. Thus, the third aim of the 
present study was to examine the developmental changes of RAS expression using 
neonatal and mature rat pancreas respectively. 
Recovery study on the regulated expression of pancreatic RAS by chronic hypoxia 
It was known that physiological adaptation developed during chronic hypoxia 
could lead to the pathophysiological changes of the tissues. It is of great interest to 
examine whether the regulated expression by chronic hypoxia could be reversible 
after returning to the normoxic condition in a defmite period of time. The expression 
of RAS component genes was therefore aimed at studying on the different period of 
normoxic recovery using standard curve-quantitative competitive RT-PCR technique 
(SC-QC-RT-PCR). 
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Regulation of pancreatic RAS by experimental pancreatitis 
Some clinical pancreatic problems such as pancreatitis, alcoholism and 
transplantation are associated with hypoxia. Since chronic hypoxia affects the RAS, it 
follows that the pathophysiological changes associated with these clinical conditions 
are likely to involve the RAS. Hence, the fmal aim ofthe present study was to define 
changes in the expression of pancreatic RAS induced by experimental pancreatitis, 
using RT-PCR, Westem blot analysis and immunohistochemistry respectively. 
i t 
fT 
• 2 9 
Chapter 2 Method 
2.1 Experimental animals and rat models 
Sprague-Dawleys rats weighing between 300-350g (approximately 6 weeks of 
age) were used in most studies, except where otherwise indicated. All the animals 
were supplied by the Laboratory Animal Services Centre of the Chinese University of 
Hong Kong. Animal models and experimental procedures have been approved by the 
I t 
Animal Ethical Committee of the Chinese University of Hong Kong. They were 
ff 
placed in a cage and reared under specific pathogen free conditions, with a controlled 
ambient temperature o f 2 0 土 1 °C; relative humidity o f 6 0 to 80% and a 14 hour light/ 
10 hour dark schedule. Standard rat chow and tap water were supplied ad libitum. 
2.1.1 Chronically hypoxic exposure of rats ‘ 
The hypoxic exposure is kept in moderate level (10% oxygen) relevant to 
clinical and physiological situations. It is well known the physiological adaptation 
developed during chronic hypoxia and the adaptation could trigger pathophysiological 
changes. Thus it is an important feature of the chronically hypoxic model that 
animals are kept in maximal exposure of hypoxia over weeks when the physiological 
adaptation could occur and compensate the hypoxic stress without the full 
development of pathophysiological events that would affect the vitality of animals. 
Therefore, we would be able to study these physiological changes at molecular and 
cellular levels for the adaptation or initial pathophysiological changes of the animal 
models. 
For the exposure of rats in chronic hypoxia, rats were kept in an acrylic chamber 
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filled with 10% 士 O.5o/o oxygen for isobaric hypoxia for 4 weeks. Animals were 
freely accessible to water and chow. The oxygen level was continuously monitored 
by a oxygen analyzer (Vacumetries, CA, USA) and was maintained by a servo-
feedback control of solenoid values which gated the inflow of pure nitrogen. The 
nitrogen was mixed with room air that was vented into the chamber by a pump (1 -2 
liter/minute). The humidity and carbon dioxide were maintained by desiccator and 
soda lime placed inside the chamber. Every 2-3 days, the chamber was opened for 15 
minutes for regular maintenance. For the normoxic controls, tim^. and age matched 
rats were kept in the same housing with breathing in room air. 
2.1.2 Recovery study of chronic hypoxia 
It is known that the physiological adaptation developed by chronic hypoxia 
could lead to pathophysiological change of the tissues. It is of interest to examine 
whether the change in response to chronic hypoxia could be reversible after returning 
to the normoxic condition in a definite period of time. 
After a 4-week hypoxic treatment as described above, hypoxic rats were returned 
to normal condition and allowed to recover for 1 week, 2 weeks, 3 weeks or 4 weeks 
were carried out. The reversibility of altered expression by chronic hypoxia during 
the recovery period can be studied. 
2.1.3 Induction of pancreatitis rats 
The details and methods for the induction of acute pancreatitis were described 
previously (Schmidt et al 1992). For the induction of pancreatitis, Wister rats 350-
450 g were used. The animals were given a short-acting anesthesia (pentobarbital 10 
mg/kg, ketamine 50 mg/kg), and the abdomen was opened by a mid-line incision. 
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The duodenum and the common bile duct were identified. A catheter (Braun, 
Barcelona, Belgium) was advanced into the common biliopancreatic duct for 5 mm 
through the papilla of Vater. The upper portion of animal was elevated 60 degree for 
5 minutes to allow the duct system to empty o f b i l e and pancreatic juice. During the 
last 2 minutes, the main hepatic duct was clamped just below the liver to facilitate 
complete drainage of pancreatic secretions. This clamp remained in place throughout 
the intraductual infusion to prevent misdirected flow into the biliary system. 
Freshly prepared glycodeoxycholic acid (GDOC, Sigma, St. Louis, USA) in 
glycylglycine-NaOH-buffered solution (pH 8.0) was injected intraductually for 10 
minutes at a pressure of 30 mmHg controlled by mercury manometer by means of an 
interposed scaled glass tube. If the infusion volume was reached faster than the 
predetermined infusion time, the fusion was stopped but the perfusion system was left 
in place until 10 minutes was reached. This was to ensure standardization of volume 
and time exposure to the infusate. The catheter was removed and the duodenal wall 
was closed . The animals were then placed back to the cages and received 
intravenous infusion of cemlein at 5 p.g/kg/hour (Takus, Pharmacia and Upjohn, 
Erlangen, Germany) for 6 hours. 
For the control groups, isotonic saline was infused intravenously and 
intraductaly instead of GDOC and cemlein. 
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2.2 Immunohistochemistry 
2.2.1 Preparation ofcyrosection 
The pancreas were dissected from the rat, and fats and other connective tissues 
were removed under a stereomicroscope. The pancreas were divided into head and 
splenic parts and prepared for frozen sectioning. Tissues were embedded in an OCT 
compound (Tissue-Tek, Sakura, Tokyo, Japan), which was employed to create a more 
uniform block and facilitate sectioning. Embedded tissues were immediately frozen 
in isopentane (-50°C), which was pre-cooled in liquid nitrogen. Consecutive 
cyrosections were then cut on a cryot6me (Shandon AS 620, Cryotome, Cheshire, 
UK) and were stored. Before immunohistochemisry, cryosections were air dried for 
30 minutes. 
2.2.2 Preparation of paraffin section 
After the pancreas was dissected from the rat, the tissues were fixed in freshly 
prepared paraformaldehyde (PFA, 4%, wt/vol) at 4°C ovemight, they were 
dehydrated sequentially in 70% ethanol, 95% ethanol and 100% ethanol. Afterwards, 
tissues were cleared in xylene for three times. The dehydrated and cleared tissues 
were embedded in molten paraffin and cast in a mould. The paraffin blocks were 
sectioned on a rotary microtome (Reichert Jung, Germany). Serial sections were 
floated out in a 55-56°C water bath. They were mounted on slides and allowed to 
dry. 
Prior to processing for immunohistochemistory, sections were de-waxed in 
xylene 5 minutes for three times, dehydrated sequentially in 70% ethanol, 95% 
ethanol and 100% ethanol for 5 minutes each. 
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2.2.3 Indirect immunoperoxidase staining 
In the present study, Avidin-biotin-complex (ABC) method was employed. 
Avidin is a 68,000 molecular weight glycoprotein with an extraordinarily high affinity 
for the small molecular weight vitamin, biotin. This give an advantage of irreversible 
binding activity. In addition, this can be effectively exploited as avidin has four 
bonding sites for biotin and most molecules can be conjugated with several molecules 
ofbiotin. 
This technique involved employment of unlabelled primary antibody, followed 
by biotinylated secondary antibody and then performed avidin and biotinylated 
horseradish peroxidase macromolecular complex (Vectastain Elite ABC Kit, Vector 
Laboratories, CA, USA) (Figure 2-1). 
Sections were fixed with freshly prepared cold 4% PFA for 8-10 minutes. After 
sufficient washing in phosphate-buffered saline (PBS, pH 7.4), sections were rinsed in 
methanol containing 0.3% H2O2 for 30 minutes to remove endogenous peroxidase 
activity. Sections were washed again and they were incubated for 30 minutes with 
diluted normal blocking serum. The serum was prepared from the species in which 
the secondary antibody is made. Excess blocking solution was removed and the 
primary antiserum was applied for 1 hour or ovemight at 4°C. The sections were 
washed with PBS and then incubated with diluted biotinylated secondary antibody for 
1 hour. After washing the sections for several times, they were incubated for 1 hour 
with ABC reagent. For the positive immunoreactivity was visualized, sections were 
reacted with Vector VIP substrate kit (Vector Laboratories, CA, USA). Sections were 
counterstained slightly with haematoxylin, dehydrated, cleared and mounted. 
Sections were then examined under light microscopy. 
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2.2.4 Indirect immunofluorescent staining 
The basic procedure for indirect immunofluorescent staining has been described 
previously (Coons et al 1955). ln the present study, the technique was employed 
coupled with the application of confocal scanning laser microscopy (MRC-lOOOUV 
confocal imaging system, BioRad, Hercules, CA, USA) equipped with an Argon ion 
UV laser and connected to an inverted microscope (Nikon Diaphot, Shinagwa, Japan). 
The choice of flurophore is particularly important to ensure that it is maximally 
excited at a wavelength close to the available laser lines. The agron 488 line is used 
with fluorescein isothiocyanate (FITC)-conjugated antibodies; The absorption 
maximum of fluorescein is very close to 488 nm and it has a conspicuously high 
quantum yield, with emission maximum at 520 nm. 
As described in the immunoperoxidase method, sections were first fixed with 
4% PFA, washed, blocking the sections with 1% BSA (wt/vol) (Sigma, St. Louis, 
»* 
USA) in PBS and incubated with diluted primary antibody. Afterwards, the sections 
were incubated with FITC-conjugated antibody (Boehringer Mannheim, Mannheim, 
Germany) at 37°C for 1 hour. They were washed shortly for 3 times, mounted and 
examined under the confocal microscopy. 
The following controls were used as negative controls throughout the present 
study: 
1. replacement of primary antibody with buffer; 
2. incubation with the non-immune serum; 
3. preadsorption of antibody with its excess antigen purified from plasma. 
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2.3 Semi-quantitative reverse transcription-polymerase chain 
reaction (RT-PCR) 
2.3.1 Total RNA extraction and quantification 
Total RNA was extracted from the tissues according to the acid guanidinium 
thiocyanate-phenol-chloroform protocol [Chomczynski and Sacchi 1986]. Rat tissues 
were homogenized in denaturing solution containing 4 M guanidinium thiocyanote 
(Boehringer Mannheim, Mannheim, Germany), 25 mM sodium citrate, pH 7; 0.5% 
sacrosyl and 0.1 M 2-mercaptoethanol. Sequentially, equal volume of phenol water 
/r 
(Gibco-BRL, Life Technologies, NY, USA), 0.1 volume of sodium acetate and 0.2 
volume of chloroform-isoamyl alcohol (49:1) was added to the homogenate. The 
final suspension was shaken vigorously and cooled on ice for 15 minutes. Samples 
% 
were centrifuged for separating RNA containing aqueous phase and protein 
containing phenol phase. The aqueous phase was then transferred to a fresh tube and 
mixed with equal volume of isopropanol for the precipitation of RNA at -20°C for 1 
hour. Centrifugation of RNA was performed and the pellet was dissolved in the 
denaturing solution, RNA was precipitated again with 1 volume isopropanol at -20°C 
for 1 hour. After centrifugation at 4°C, RNA was washed with 70% ethanol, 
sedimented , air dried and dissolved in 50^1 diethyl pyrocarbonate (DEPC) (Acros, 
New Jersey, USA) treated water. 
Total RNA was quantified by spectrophotometer (UV-1601, Shimadzu, Kyoto, 
Japan). Total RNA concentration was calculated from the value of absorbance at 
wavelength 260nm (O.D. 260) x 40 x dilution factor and the purity of RNA obtained 
was determined by the ratio of O.D. 280 to O.D.260. The value lining between 1.6 
and 2.0 was considered as pure enough. 
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2.3.2 Reverse transcription (RT) 
Total RNA (10 p.g) was subjected to first-strand by Superscript Preamplication 
System (Gibco-BRL, Life Technologies, NY, USA). A 20-^il reaction volume 
containing random hexamer, IX first strand buffer (250 mM Tris-HCl, pH 8.3; 375 
mM KC1, 15 mMMgCh), 1,4-dithiothreitol (DTT), deoxynucleotide (dNTP) mix and 
Superscript II transcriptase was incubated at 42°C for 50 minutes, the reaction was 
inactivated by heating at 70°C for 15 minutes. To remove RNA-complementary to 
the cDNA, RNase H was added and incubated at 37 °C for 20 minutes. 
2.3.3 Polymerase chain reaction (PCR) 
The resultant cDNA was subjected to PCR reaction. Different sets of 
oligonucleotide primers based on the corresponding RAS component genes were 
synthesized (Gibco-BRL, Life Technologies, NY, USA). The sequences of the 
primers were shown as following: 
RAS gene primers Sense Anti-sense 
Angiotensinogen TTCAGGCCAAGACCTCCC CCAGCCGGGAGGTGCAGT 
~ R ^ CTGGGAGGCAGGACCTACAC~"TTAGCGGGCCAAGGCGAACC 
ATia receptor GCACACTGGCAATGTAATGC~"GTTGAACAGAACAAGTCACC"~ 
ATib receptor GCCTGCAAGTGAAGTGATTT~~TTTAACAGTGGCTTTGCTCC 
AT2 receptor CAAGACTTGGTCACGGGT TCTGGCTGTGGCTGACT 
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PCR was carried out in a 20-|il reaction volume containing IX PCR buffer (20 
mM Tris-HCl, pH 8.4; 50 mM KC1), 1.5 mM MgCl2, 0.2 mM dNTP mix, 0.5 ^iM 
corresponding sense and anti-sense primers, template DNA and Taq DNA Polymerase 
(Gibco-BRJL, Life Technologies, NY, USA). The reaction was started at 94°C for 
denaturing, then annealing at different temperature for different gene of interests and 
finally extending at 72°C. The cycle was repeated for 25-35 cycles. 
% 
2.3.4 GeI electrophoresis 一 
The PCR products were analyzed on a agarose gel, (2 % agarose wt/vol, in 1 X 
TAE buffer, 0.04 M Tris-acetate, 0.001 M EDTA). The gel was stained with 
ethidium bromide (Gibco-BRL, Life Technologies, NY, USA), and visualized on a 
UV illuminator equipped with a camera. 
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2.4 Western blot analysis 
2.4.1 Extraction of angiotensinogen protein 
Rat tissues were homogenized at 4°C in solution (1:9 wt/vol) containing 10 mM 
ethylenediaminetetraaectic acid (EDTA), l m M phenylmethylsulfonyl floride (PMSF). 
The homogenate was spun down (10,000 xg) and the supernatant was adjusted to pH 
4.5 with acetic acid and left at 4°C for 1 hour. The reaction mixture was centrifuged 
again (1000 xg) and the resultant supernatant was collected. “ The protein was 
determined before sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE). 
、 2.4.2 Extraction of angiotensin receptor membrane protein 
Rat tissues were homogenized at 4°C in solution (1:9 wt/vol) containing 100 
•* 
mM EDTA, and 1 mM PMSF. The homogenate was sedimented at low speed (1,000 
xg) for 10 minutes. The supernatant was sedimented again but with a high speed 
(30,000 xg) for 30 minutes. The membrane fraction protein was finally called for 
protein assay. 
2.4.3 Quantification of protein concentration 
The protein concentration was quantified by Bio-Rad Protein Assay (Bio-Rad, 
CA, USA). It is involved with the addition of an acidic dye to protein solution, and 
subsequent measurement at 595 nm with a spectrometer (UV-1601, Shimadzu, Kyoto, 
Japan). Relative measurement of protein concentration was provided by comparing to 
a standard curve. 
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One volume of dye reagent concentrate was diluted with four volume of distilled 
water. Equal amount of diluted dye solution was added to different concentration 
(0.2, 0.4, 0.6, 0.8 mg/ml) o fbov ine serum abumin (BSA) which was used as standard, 
and protein samples respectively. They were incubated at room temperature for 5 
minutes and absorbance at 595 nm were measured. 
2.4.4 Sample preparation 
One part of protein sample was mixed with two parts of laemmli sample buffer 
1» 
(Bio-Rad, CA, USA) (62.5 m M Tris-HCl, pH 6.8; 25% glycerol; 2% SDS and 0.01% 
Bromophenol Blue) containing 5% P-mecaptoethanol. It was heat denatured at 100°C 
for 5 minutes. 
2.4.5 Sodium dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
The procedures for SDS-PAGE were based on the previous report (Laemmli 
1970). Polyacrylamide gel electrophoresis is a pivotal procedure in protein 
characterization. The analytical reactions probing the structure and composition of 
the target protein are carried out after the separation of a complex mixture of 
macromolecules by PAGE. 
The electrophoresis system is called discontinuous electrophoresis in which two 
layers of gel were casted in the same slab gel apparatus. The upper layer called 
stacking gel containing 4% acrylamide allowing protein samples to be concentrated 
into stacked bands before entering the lower layer called separating gel layer with 
12% acrylamide. Apart from different acrylamide concentration, they also contain 
10% SDS which is an anionic detergent，polymerizing agent ammonium persulfate 
(APS) and addition ofN,N,N,-N'-tetramethylene-diamine (TEMED) for accelerating 
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the polymerization. 
Heat denatured protein samples were added to the gel for electrophoresis (Mini-
PROTEAN II System, Bio-Rad, CA, USA) at 120V for 1.5 hour. 
2.4.6 EIectroblotting and immunodetection ofproteins 
After completion of gel electrophoresis, the gel was equilibrated in 
electroblotting buffer (48 mM Tris/ 39 mM glycine containing 20% methanol) for 30 
: minutes. Protein was immoblized on a polyvinylidene difluoride (PVDF) membrane 
It 
(Micron MA, USA). According to manufacturer's instruction, membranes were firstly 
immersed in methanol for about 10 seconds, then equilibrated in electroblotting buffer 
for 30 minutes. Electroblotting was carried out by Semi-Dry Transfer System (Bio-
Rad, CA, USA) at 15V for 30 minutes. � 
Membranes were blocked by blocking solution (5% nonfat skimmed milk) for 1 
hour and washed in 0.1% Tween-20 in PBS. The membrane was'then incubated with 
primary antibody at 4°C ovemight. The membrane was washed twice with washing 
solution, and then incubated with peroxidase labeled secondary antibody at room 
temperature for 1 hour. After sufficient washing, the membrane was ready for 
detection by ECL detection system (Amersham, Buckinghamshire, UK) (Figure 2-2). 
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Separation of protein sample by SDS-PAGE 
^ ^ 
Transfer to PVDF membrane 
因 暴 
I* 
Block the non-specific sites 
^^ i " v ^ 
Incubation with primary antibody 
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Incubation with HRP-Iabelled conjugated antibody 暴 
ECL detection 
s ^^ 
Exposure to film 
Figure 2-3: Summary on Westem blot analysis protocol 
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2.5 Standard curve, quantitative competitive RT-PCR (SC-QC-RT-
PCR) 
The use o fRT-PCR with internal RNA competitive genes (competitors) provides 
a means for measuring absolute amounts of mRNA transcripts in cells or tissues. The 
standard curve is produced with different amounts of standard (native) RNA 
amplified with one constant amount of competitor RNA. The amount of transcripts in 
an unknown mRNA sample can be determined directly by RT-PCR of the sample 
with the same amount of competitor RNA and comparison Qf the ratio products 
derived from the standard curve. ,The basic principle for SC-QC-RT-PCR was 
schematically present in the figure below (Figure 2-3). 
2.5.1 Preparation of native and competitor templates � 
RT-PCR was used to amplify cDNA products containing the native sequence 
一 
and cloned the products into PCR cloning vector (pCR2.1 or pGEM-T) to generate 
plasmids. Competitor plasmids have been generated using restriction enzymes to 
delete an internal fragment and also cloned into a vector. The native and competitor 
were sequenced to confirm the identity and orientation of the inserts. Plasmids were 
linearized by the proper restriction enzymes and in vitro transcription was carried out 
in a 20-^il reaction mixture containing linearized plasmid, IX transcription buffer, 
lOmM nucleotide mix (NTP mix), RNA inhibitor and T7 RNA polymerase 
(Boehringer Mannheim, Mannheim, Germany). The reaction mixture was incubated 
at 37°C for 2.5 hours. After in vitro transcription, plasmids were removed by 
treatment with DNAse I (Boehringer Mannheim, Mannheim, Germany) at 37°C for 
15 minutes. In vitro transcribed RNA was extracted with phenol/ chloroform/ 
4 5 
isoamyl alcohol (50:49:1) and precipitated with 0.3 M sodium acetate and two volume 
of 100% ethanol. RNA precipitated was centrifuged, washed with 70% ethanol, air 
dried and dissolved in water treated with DEPC. The RNA concentration was then 
determined by optical density O.D. 260 absorption. 
2.5.2 RT-PCR 
Same amount (2^il) of serially diluted native RNA (0.2, 0.4, 0.8, 1.6, 3.2, 6.4’ 
12.8 and 25.6 attomole) and constant competitor RNA (4 attomole, 2^1) was added to 
•t 
different tubes to carry out the reverse transcription. For the unknown samples, same 
amount (2fil) of RNA sample in combination of competitor RNA (4 attomole, 2^1) 
was used instead. Reverse transcription an polymerase chain reaction were carried 
out as the same components and conditions as described previously. � 
PCR products were analyzed on a 2% agarose gel and visualized by staining 
with ethidium bromide. The gel image was analyzed using image analysis program 
(Molecular Dynamics Image Quant, Sunnyvale, CA, USA). A ratio o f b a n d intensity 
of native vs. competitor on each land was calculated and a standard cure can be 
obtained from the standard. Also, ratio of unknown RNA sample to competitor band 
intensity was calculated, the exact amounts of RNA transcripts were found out by 
comparing to the standard curve. 
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Figure 2-4: Schematic drawing ofSC-QC-RT-PCR 
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2.6 Data analysis 
All the gel image from RT-PCR and image from Western blot analysis were 
quantified by image analysis (Molecular Dynamics Image Quant, Sunnyvale, CA, 
USA). Results were expressed as the mean 土 SE. Statistical comparisons were made 
by unpaired t-test for comparison between groups (Sigma Plot, Jandel, CA, USA). 
Values o f P <0.05 were considered statistically significant. 





Chapter 3 Result 
3.1 Existence ofa local RAS in the rat pancreas 
3.1.1 Expression of major RAS component gene 
In order to demonstrate the presence of a local RAS in the rat pancreas, the 
mRNA expression of major components in the pancreas should be the definite 
evidence. RT-PCR coupled with specific primers for the corresponding 
•• 




Results from RT-PCR showed that mRNAs of angiotensinogen, which is the 
indispensable component of a local RAS, was found to be expressed in the rat 
pancreas, although the level of expression appeared to be low when compared with 
% 
that in the liver and kidney (Figure 3-1). In addition, renin mRNA which is the 
critical and determining enzyme for the conversion of angiotensinogen into the 
physiologically active angiotensin II was also present in the rat pancreas (Figure 3-2). 
Moreover, mRNAs of angiotensin receptor subtype genes, namely ATia (Figure 3-3), 
ATib (Figure 3-4) and AT2 (Figure 3-5) were also found to be expressed in the rat 
pancreas as well as that in the adrenal gland which was employed as a positive 
control. All the data showed that the pancreas possesses the major RAS component 
genes. 
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Figure 3-1: RT-PCR analysis of angiotensinogen mRNA in rat pancreas, liver and kidney. 
Lane M, DNA marker (q>X174 RF/HaeIII fragments); lane 1，RT-PCR amplification of 
angiotensinogen mRNA in pancreas; lane 2, RT-PCR amplification of angiotensinogen 
mRNA in liver; lane 3, RT-PCR amplification of angiotensinogen mRNA in kidney; lane 
4, RT-PCR amplification of GADPH in pancreas; lane 5, control in which no reverse 
transcriptase was added for RT-PCR of GADPH in the pancreas. The arrow (312 bp) 
indicates the expected size o f P C R products from angiotensinogen. 
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Figure 3-2: RT-PCR analysis of renin mRNA in rat pancreas and kidney. Lane M, DNA 
marker; lane 1，RT-PCR amplification of renin mRNA in pancreas; lane 2, RT-PCR 
amplification of renin mRNA in kidney; lane 3，RT-PCR amplification of GADPH in 
pancreas; lane 4, control in which no reverse transcriptase was added for first strand 
synthesis of GADPH in the pancreas. The arrow (853 bp) indicates the expected size of 
PCR products from renin. 
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Figure 3-3: RT-PCR analysis of ATj^ mRNA in rat pancreas, adrenal gland and kidney 
Lane M, DNA marker; lane 1, RT-PCR amplification of AT,^ mRNA in pancreas; lane 2, 
RT-PCR amplification of AT,3 mRNA in adrenal gland; lane 3，RT-PCR amplification 0 
ATia mRNA in kidney; lane 4, RT-PCR amplification of GADPH in pancreas; lane 5 
control in which no reverse transcriptase was added for first strand synthesis of GADPH in 
the pancreas. The arrow (385 bp) indicates the expected size of PCR products from AT,3. 
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Figure 3-4: RT-PCR analysis of AT,b mRNA in rat pancreas, adrenal gland and kidney. 
Lane M, DNA marker; lane 1, RT-PCR amplification of AT,b mRNA in pancreas; lane 2， 
RT-PCR amplification of AT,b mRNA in adrenal gland; lane 3, RT-PCR amplification of 
AT�b mRNA in kidney; lane 4，RT-PCR amplification of GADPH in pancreas; lane 5, 
control in which no reverse transcriptase was added for first strand synthesis of GADPH in 
the pancreas. The arrow (204 bp) indicates the expected size o f P C R products from AT,b. 
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Figure 3-5: RT-PCR analysis of ATj mRNA in rat pancreas and adrenal gland. Lane M, 
DNA marker; lane 1, RT-PCR amplification of AT^ RNA in pancreas; lane 2, RT-PCR 
amplification of AT^ mRNA in adrenal gland; lane 3，RT-PCR amplification of GADPH in 
pancreas; lane 4, control in which no reverse transcriptase was added for first strand 
synthesis of GADPH in the pancreas. The arrow (511 bp) indicates the expected size of PCR 
products from ATj. 
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3.1.2 Expression of angiotensinogen protein 
In order to elucidate the presence of the precursor angiotensinogen protein in the 
rat pancreas, SDS-PAGE and Westem blot analysis were performed. Polyconal 
antibody raised against rat angiotensinogen [Thomal and Semia 1988] was employed 
to detect angiotensinogen protein in rat pancreas homogenate. Two isoforms of 
angiotensinogen protein of about 60 kDa and 56 kDa were apparently expressed in the 
rat pancreas. These two isoforms were in close agreement with that of 
angiotensinogen purified from plasma, which was used as a positive control in the 
experiment (Figure 3-6). •‘ 
3.1.3 Localization of angiotensinogen and renin proteins 
The precise localization of angiotensinogen and renin in the pancreas were 
studied by immunohistochemistry using specific antibodies against the purified rat 
angiotensinogen and renin respectively. Antibody raised from rabbit against rat 
angiotensinogen [Thomas and Semia 1988] and from sheep against rat renin [Taugner 
et al 1982] were employed respectively. Inununohistochemical examination of the rat 
pancreas showed that immunoreactivity for angiotensinogen (Figure 3-7) and renin 
(Figure 3-8) appeared to be localized exclusively in the pancreatic ducts and blood 
vessels. 
Under higher magnification of pancreatic sections, intensive immunostaining 
was specifically localized in the cytoplasm of epithelial cells of pancreatic ducts. In 
addition, immunostainings for angiotensinogen and renin were also localized in the 
endothelial lining of the blood vessels. Weak immunoreactivity was also found at 
muscles lying the blood vessels and ducts. The specificity of the immunostaining was 
validated by negative control experiments in which specific antibody was replaced 
with non-immune serum or buffer. 
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Figure 3-6: Westem blot analysis for angiotensinogen protein of rat pancreas. Lane Ao 
shows the detection of two isoforms of angiotensinogen with molecular sizes of about 60 
and 56 kDa respectively from plasma of nephrectomized rats. A major protein band o 
about 60 kDa was detected fromlO ^ig protein (lane 1) and from 5 fig protein (lane 2). 
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Figure 3-7: Immunohistochemical localization of angiotensinogen protein in rat pancreas, 
(a) Angiotensinogen immunoreactivity was locaUzed predominately in the epithelial ceUs 
of pancreatic ducts (PD) as well as in the endotheUal Uning of pancreatic blood vessels 
(BV). Magnification xlOO. (b) Higher magnification of pancreatic sections showing 
intense immunostaining in vascular endotheUum. Magnification x200. (c) Higher 
magnification of pancreatic sections showing intensive immunostaining in pancreatic 
ductal epitheUum. Magnification x200. (d) Consecutive pancreatic section showing the 
specificity in which the primary antibody was substituted with buffer. Magnification x 
100. 
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Flgure 3-8: Inminohistochemical locaUzation of renin protein in rat pancreas. (a) Renin 
immunoreactivity was locaUzed in the epitheUal ceUs of pancreatic ducts (PD). 
Magnification x200. (b) Higher magnification of pancreatic sections showing intense 
immunostaming observed in vascular endotheUum (BV). Magnification x200. 
Consecutive pancreatic sections showing the specificity in which the primary antibody was 
substituted with buffer. No immunoreactivity was found in the epitheUal ceUs of 
pancreatic ducts (c) and blood vessels (d). Magnification xlOO. 
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3.2 Effect of chronic hypoxia on RAS expression in neonatal rat 
3.2.1 Effect of chronic hypoxia on angiotensinogen protein expression 
The expression change of angiotensinogen protein by chronic hypoxia was 
investigated by Westem blot analysis. A predominant band of about 60 kDa was 
consistently detected in both normoxic and hypoxic rat pancreas. The specificity of 
the antibody was validated as the antibody detected a band which had a similar 
molecular size with that of angiotensinogen isoforms purified from the 
nephrectomized rat plasma. Under hypoxic treatment, angiotensinogen protein 
expression was found increased significantly when compared to that of normoxic 
control. The relative level of changes was about 3-fold as demonstrated by image 
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Figure 3-9: (a) Westem blot analysis of angiotensinogen protein expression by chronic 
hypoxia in the neonatal rat pancreas. Lane Ao, plasma angiotensinogne purified from the 
nephrectomized rat. A major band of 60 kDa was detected; lane C, angiotensinoge 
expression by normoxic rat; lane H, angiotensinogen expression by hypoxic rat. (b) 
Relative expression of angiotensinogen protein in hypoxic pancreas compared to that i 
normoxic pancreas. The data are expressed as mean 土 SE. 
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3.2.2 Optimization of semi-quantitative RT-PCR for RAS gene analysis 
For the interpretation of semi-quantitative RT-PCR data to be meaningful, PCR 
reaction should be terminated when the products from genes ofinterest are detectable 
and are amplified within linear range. The linear range of amplification occurs in the 
PCR cycles when reaction components are still in excess and the PCR products are 
accumulating at a constant rate. Thus, two appropriate sets of experiments were 
conducted on each gene for validation ofPCR amplification in the logarithmic phase. 
Different amounts of cDNA mixture were amplified for 27 cycles ofPCR using 
primers for the RAS components and p-actin. A linear range was observed between 
i i 
the increasing cDNA (0.4-1.6 ^il) used and the amount ofPCR product (Figure 3-10). 
/r 
The 0.8 i^l of cDNA mixture was subjected to PCR amplification in a 20-^il 
reaction system for 25-35 cycles. The amount of amplified PCR product was plotted 
as a function of the number ofPCR cycles. The figures demonstrated the linear phase 
� 
of the PCR amplification reaction for various RAS gene components. The linear 
range of PCR product lies between 25-28 cycles for angiotensinogen (Figure 3-11) 
and ATia receptor (Figure 3-12), while that lies between 27-30 cycles for ATib 
(Figure 3-13) and AT2 receptor (Figure 3-14). 
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Figure 3-10: Optimization of the RT-PCR analysis for angiotensinogen mRNA in normoxic 
(circle) and in hypoxic pancreas (square). Various amounts of cDNA mixture (RT solution) 
with 27 cycles were employed for amplification reaction. 
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Figure 3-11: Optimization of the RT-PCR analysis for angiotensinogen mRNA in 
normoxic (circle) and in hypoxic pancreas (square). A fixed amount of cDNA mixture was 
amplified for several different PCR cycles. 
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Figure 3-12: Optimization o f t h e RT-PCR analysis for AT„ mRNA in normoxic (circle) 
and in hypoxic pancreas (square). A fixed amount of cDNA mixture was amplified for 
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Figure 3-13: Optimization o f t h e RT-PCR analysis for AT,i,mRNA in normoxic (circle) and 
in hypoxic pancreas (square). A fixed amount of cDNA mixture was amplified for several 
different PCR cycles. 
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Figure 3-14: Optimization o f t h e RT-PCR analysis for ATj mRNA in normoxic (circle) and 
in hypoxic pancreas (square). A fixed amount of cDNA mixture was amplified for several 
different PCR cycles. 
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3.2.3 Effect of chronic hypoxia on RAS components gene expression 
Angiotensinogen 
Li accordance with the protein level, the relative angiotensinogen mRNA 
expression was also found to be increased by chronic hypoxia when compared to that 
of control. The relative expression of mRNA for angiotensinogen to p-actin in 
hypoxic pancreas was upregulated by 2-fold when compared to that in normoxic 
pancreas. From the result, it was found that the p-actin expression remained 
relatively constant in both normoxic and hypoxic treatment. This implied that p-actin 
was suitable as the relative control for comparison (Figure 3-15). •‘ 
r 
ATia andATib receptor 
The specific expression change of ATi receptor subtypes ATia and ATib were 
studied using RT-PCR in use with corresponding primers. A differential effect on 
% 
ATi expression change of chronic hypoxia was observed in the neonatal rat pancreas. 
There was no apparent change in ATia mRNA expression- change by chronic 
treatment. Although there was a slightly increased in expression, but the change was 
not statistically significant (Figure 3-16). Di contrast to ATu, there was a significant 
2-fold increase in ATib mRNA expression (Figure 3-17). 
AT2 receptor 
Ln addition to ATi receptor, another angiotensin receptor subtype AT2 was also 
investigated. Chronic hypoxia had a marked effect on AT2 mRNA expression, 
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Figure 3-15: (a) RT-PCR analysis of angiotensinogen m R N A by chronic hypoxia in the 
neonatal rat pancreas. Lane M, DNA marker; lane 1，angiotensinogen expression in control 
rat; lane 2，angiotensinogen expression in hypoxic rat; lane 3, p-actin expression in control 
rat; lane 4，p-actin expression in hypoxic rat. (b) The relative expression of angiotensinogen 
/p-actin mRNA. The data are expressed as mean 土 SE. 
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Figure 3-16: (a) RT-PCR analysis of AT^^ mRNA by chronic hypoxia in the rat pancreas. 
Lane M, DNA marker; lane 1’ AT,^ expression in control rat; lane 2，AT,^  expression in 
hypoxic rat; lane 3’ p-actin expression in control rat; lane 4，P-actin expression in hypoxic rat. 
(b) The relative expression o f A T J P _ a c t i n mRNA. The data are expressed as mean 土 SE. 
69 
a mm^^^^rn 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^H ^^ ^^ ^^ ^^ k^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ l^ 
bp > ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ M 
—^^^H 
»» 
b M 1 2 3 4 
fT 
60 n < z ^ 
E * 
c � 
“ 4 。 - _ 
< *； -,,Hti> .< -^f 
^ ^ -J Sto 、 
k t . Q W ^ 、 - > V ^ ' 
fi i l l 
Control Hypoxia 
Figure 3-17: (a) RT-PCR analysis of AT,b m R N A by chronic hypoxia in the neontal rat 
pancreas. Lane M, DNA marker; lane 1’ AT,b expression in control rat; lane 2, AT,b 
expression in hypoxic rat; lane 3，P-actin expression in control rat; lane 4, P-actin 
expression in hypoxic rat. (b) The relative expression of AT,b/P-actin mRNA. The data 
are expressed as mean 土 SE. 
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Figure 3-18: (a) RT-PCR analysis o f A T j mRNA by chronic hypoxia in the neonatal rat 
pancreas. Lane M, DNA marker; lane 1，AT! expression in control rat; lane 2, AT, 
expression in hypoxic rat; lane 3，P_actin expression in control rat; lane 4，P-actin 
expression in hypoxic rat. (b) The relative expression of AT2/p-actin mRNA. The data 
are expressed as mean 土 SE. 
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3.3 Effect of chronic hypoxia on RAS expression in adult rat 
3.3.1 Expression changes ofRAS proteins 
Angiotensinogen protein 
Westem blot analysis showed clearly that there was an increase in 
angiotensinogen protein expression after chronic hypoxia. A major protein band of 
60 kDa was found in both normoxic and hypoxic rat. The intensity ofthis band was 2-
fold greater in hypoxic rats (Figure 3-19). 
ATi receptor protein 
11 
Protein expression of angiotensin receptor ATi was also studied. A major 
protein band size of about 50 kDa was detected consistently in both normal and 
chronic hypoxic pancreas. Unlike angiotensinogen protein expression, there was no 
significant change in ATi protein expression when compared with that in normoxic 
% 
rat. The specificity of the antibody was demonstrated as the antibody unequivocally 
detected a major band of about 50 kDa in the kidney which was employed as a 
positive tissue for the expression of ATi receptor (Figure 3-20). 
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Figure 3-19: (a) Westem blot analysis of angiotensinogen protein expression in hypoxic 
mature rat • Lane Ao, plasma angiotensinogen purified from nephrectomized rat. A major 
band of about 60 kDa was detected; lane C, the expression in normoxic pancreas; lane H, 
the expression in hypoxic rat. (b) Relative expression of angiotensinogen protein in 
hypoxic mature rat was compared with that in normoxic pancreas. The data are expressed 
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Figure 3-20: (a) Western blot analysis of AT, protein expression in hypoxic mature rat . 
Lane Kid, AT, protein expression in kidney. A major band of about 50 kDa was detected; 
lane C, the expression in normoxic pancreas; lane H, the expression in hypoxic rat. (b) 
Relative expression of AT, protein in hypoxic mature rat was compared with that in 
normoxic pancreas. The data are expressed as mean 士 SE. 
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3.3.2 Expression changes of RAS component genes 
Angiotensinogen 
ki consistent with its protein level, an increase in angiotensinogen mRNA 
expression was also found during chronic hypoxia. The relative expression of mRNA 
for angiotensinogen to p-actin in hypoxic pancreas was up-regulated by 4-fold when 
compared to that in normoxic pancreas. From the result, it found that the expression 
of p-actin remained unchanged in both normoxic and hypoxic treatment. This 
implied that p-actin was suitable as the relative control for comparison (Figure 3-21). 
%* 
ATia andATib receptor , 
The specific expression change on ATi receptor subtypes ATia and ATib was 
also studied in the adult rat pancreas. A receptor subtype specific change was found. 
hi constant to observation in the neonatal rats, a significant increase in expression of 
ATia by 2-fold was found (Figure 3-22). However, ATib expression did not find any 
significant change by chronic hypoxia in the chronically hypoxic pancreas (Figure 3-
23). The data imply that there was a developmental expression changes of ATu and 
ATib during hypoxia. 
AT2 receptor 
Di line with that found in neonatal rat, a marked increase in expression of AT2 
receptor was found during chronic hypoxia. The relative expression of AT2 in 
hypoxic pancreas was up-regulated by 3-fold as compared to that in normoxic 
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Figure 3-21: (a) RT-PCR analysis of agniotensinogen mRNA in mature hypoxic rat. 
Lane M, DNA marker; lane 1, expression in normoxic rat; lane 2, expression in hypoxic 
rat; lane 3，p-actin expression in normoxic rat; lane 4，P-actin expression in hypoxic rat. 
The arrows indicate the expected size of amplified products from angiotensinogen (312 bp) 
and P-actin (240 bp), (b) The relative expression of angiotensinogen/p-actin mRNA. The 
data are expressed as mean 土 SE. 7 6 
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Figure 3-22: (a) RT-PCR analysis of AT!a mRNA in mature hypoxic rat. Lane M，D N A 
marker; lane 1, expression in normoxic rat; lane 2, expression in hypoxic rat; lane 3, P-actin 
expression in normoxic rat; lane 4, p-actin expression in hypoxic rat. The arrows indicate the 
expected size ofampl i f ied products from AT,^ (385 bp) and P-actin (240 bp), (b) The relative 
expression ofAT,, /p-act in mRNA. The data are expressed as mean 士 SE. 7 7 
a 
^m,;^;2^^^^^^^^^^^^^^ 
^ R ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^M ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
240 bp ——> ^ ^ ^ ^ ^ ^ ^ ^ B H H H I | 
204 bp — > ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ I m ^ i ^ ^ i ^ 
M. 1 2 3 4 
b 
100 n < Z 0^ E 
.E 80 - � ^ 
ra 
I ca � -
- 2 60 -
H- 知 • < = u_ o o o 
C名 .2 ^ 40 - T 
!」_南 
Control Hypoxia 
Figure 3-23: (a) RT-PCR analysis o fAT,b m R N A in mature hypoxic rat. Lane M, DNA marker; 
lane 1, expression in normoxic rat; lane 2，expression in hypoxic rat; lane 3，p_actin expression in 
normoxic rat; lane 4, p_actin expression in hypoxic rat. The arrows indicate the expected size of 
amplified products from AT,b (204 bp) and P_actin (240 bp), (b) The relative expression of 
AT,b/p-actin mRNA. The data are expressed as mean 土 SE. 
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Figure 3-24: (a) RT-PCR analysis of AT2 mRNA in mature hypoxic rat. Lane M, DNA 
marker; lane 1，expression in normoxic rat; lane 2, expression in hypoxic rat; lane 3, P-actin 
expression in normoxic rat; lane 4，p-actin expression in hypoxic rat. The arrows indicate 
the expected size of amplified products from ATj (511 bp) and P-actin (240 bp), (b) The 
relative expression ofATj /p-ac t in mRNA. The data are expressed as mean 土 SE. 
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3.3.3 Cellular localization of angiotensinogen and ATi receptor 
In order to elucidate the precise localization of increased expression in hypoxic 
rat pancreas, immunohistochemical studies were employed coupled with specific 
antibody against angiotensinogen. Enhanced immunoreactivity for angiotensinogen 
in hypoxic pancreas appeared to be localized mainly in exocrine pancreas. More 
intense immunoreactivity was predominantly localized to the endothelia and epithelia 
of blood vessels "and pancreatic ducts respectively in hypoxic pancreas when 
compared with those in normoxic pancreas (Figure 3-25). 
The localization of expression change in ATi receptor was also examined. 
I* 
Merestingly, enhanced immunoreactivity for ATi receptor was also locaHzed as that 
产 
of angiotensinogen found. It seems different from the Westem blot analysis in which 
no significant expression change was found. The enhanced immunoreactivity was 
predominantly localized to the endothelia of blood vessels and epithelia of pancreatic 
% 
ducts in hypoxic rats. On the other hand, less enhanced immunoreactivity was 




Figure 3-25: CeUular locaUzation of angiotensinogen protein in normoxic and hypoxic 
pancreas from the mature rats, (a) Less intense immunoreactivity for angiotensinogen 
protein was locaUzed in the pancreatic vasculature and ductal system in normoxic rat. (b) 
More intense immunoreactivity for angiotensinogen was locaUzed predominantly in the 
endotheUa and in the epitheUal ceUs of blood vessek and pancreatic ducts respectively in 
hypoxic rat. Note: No immunoreactivity was found in the acinar ceUs from both normoxic 
and hypoxic pancreas. The specificity of immunostaining was vaHdated by the substitution 
ofprimary antibody with buffer either in (c) normoxic or (d) hypoxic pancreas. 
81 
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Figure 3-26: CeUuter locaUzation of ATi receptor protein in normoxic and hypoxic 
pancreas from mature rats, (a) Less intense immunoreactivity for ATi protein was 
locaUzed in the pancreatic vasculature and ductal system in the normoxic rat. (b) More 
mtense immunoreactivity for ATi was locaUzed predominantly in the endotheUa and in the 
epitheUai ceUs ofblood vessels and pancreatic ducts respectively in the hypoxic rat. Note. 
Less intense immunoreactivity for ATi was found in the acinar ceUs from both normoxic 
and hypoxic pancreas. The specificity of inminostaining was vaHdated by the substitution 
ofpnmary antibody with buffer either in (c) normoxic or (d) hypoxic pancreas. 
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3.3.4 Recovery study on the expression 0 f A T 2 receptor mRNA 
Standard Curve Methodology of QC-RT-PCR 
Standard curve QC-RT-PCR was used to quantify the mRNA expression 0 f A T 2 
receptor in order to assess its reversibility after returning to the normoxic condition in 
a defmlte period of time. By using 30 cycles of PCR amplification, the standard 
curve showed a linear relationship between the log ratio 0 f A T 2 native RNA to that of 
the competitor RNA and log amount of serial dilution of native RNA (0.4-25.6 
attmole)OFigure 3-27). 
It 
Reversibility 0fAT2 receptor expression 
产 
After returning to normoxic condition for 1 week, the mRNA 0 f A T 2 receptor in 
hypoxic rat still remained marked increase. However, this marked up-regulation of 
AT2 expression by chronic hypoxia was leveling off to normal when compared to the 
% 
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Figure 3-27: Standard curve for QC-RT-PCR. (a) 0.4-25.6 attmole of native AT^ RNA 
was co-amplified with 4 attmole of competitor for 30 cycles, (b) The log ratio of native to 
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Figure 3-28: Quantitation of ATj mRNA in different (1 week, 2 weeks, 3 weeks and 4 
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3.4 Effect of experimental pancreatitis on RAS expression 
3.4.1 Histopathological examination of pancreatitis 
There are four major criteria for experimentally-induced pancreatitis, namely, 
edema, acinar cell necrosis, hemorrhage and inflammation. Among them, edema and 
necrosis were examined based on the observation of histological changes of pancreas 
during the experimentally induced pancreatitis. Histological sections were stained 
with hematoxylin and erosin (Figure 3-29). 




The expression ofangiotensinogen protein in pancreatitis was investigated using 
Westem blot analysis. A predominant protein band of about 60 kDa was consistently 
detected both in the normal and pancreatitis pancreas. The expression of 
% 
angiotensinogen protein in pancreatitis was greatly enhanced when compared with 
that in control. The relative level of changes in pancreatitis was significantly 
increased by about 6-fold, as demonstrated by image analysis (Figure 3-30). 
AT� receptor protein 
Apart from angiotensinogen protein, the expression o fATi receptor protein was 
also studied. A major protein band size of about 50 kDa was found consistently in 
both normal and pancreatitis pancreas. However, there was no significant change in 
ATi protein expression in pancreatitis when compared to that ofnormal pancreas. A 
similar size of protein band (50 kDa) was unequivocally detected in kidney which was 




Figure 3-29: Histopathological examination in experimentaUy-induced pancreatitis, 
(a) Edema, magnification xlOO; (b) Higher magnification x200; (c) Acinar ceU necrosis, 
magnification xlOO; (d) Higher magnification x200. 
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Figure 3-30: (a) Westem blot analysis of angiotensinogen protein expression in 
pancreatitis rat. Lane Ao, plasma angiotensinogen purified from nephrectomized rat. A 
major band of about 60 kDa was detected; lane C, the expression in normal pancreas; lane 
P, the expression in pancreatitis rat. (b) Relative expression of angiotensinogen protein in 
pancreatitis compared with that in normal pancreas. The data are expressed as mean 土 SE. 
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Figure 3-31: (a) Westem blot analysis o f A T ! protein expression in rat pancreatitis. Lane 
Kid, ATj protein purified from rat kidney. A major band ofabout 50 kDa was detected; 
lane C, the expression in normal pancreas; lane P, the expression in pancreatitis rat. (b) 
Relative expression of AT! protein in pancreatitis compared with that in normal pancreas. 
The data are expressed as mean 士 SE. 
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3.4.3 Effect of pancreatitis on RAS components gene expression 
Angiotensinogen 
In parallel with protein level, angiotensinogen mRNA expression was also 
greatly enhanced in pancreatitis when compared with that in normal pancreas, as 
demonstrated by RT-PCR technique. The expression of p-actin which is a 'house-
keeping gene' and used as a positive control, remained unchanged in pancreatitis 
when compared with that in normal pancreas. The relative expression of mRNA for 
angiotensinogen to p-actin in pancreatitis was increased by 4-fold when compared 
with that in normal pancreas, the size of amplified PCR product from normal and 
1» 
pancreatitis pancreas was comparable to those in our studies as described above. 
(Figure 3-32). , 
ATia and ATjt receptor subtypes 
to addition to ATi receptor protein expression, change in mRNA expression of � 
ATi receptor subtypes was studied. Li combination with specific primer, ATia and 
ATib receptor subtypes expression were elaborated. A differential effect of 
pancreatitis on mRNA expression of ATia and ATib subtype was observed. There 
was a significant increase of mRNA expression for ATia subtype in pancreatitis by 3-
fold (Figure 3-33) whereas no apparent changes in mRNA expression for ATib 
subtype in pancreatitis (Figure 3-34). 
9 0 
AT2 receptor 
The effect of pancreatitis on regulation of AT2 receptor expression was also 
studied. Diterestingly, pancreatitis caused a marked increase in mRNA expression for 
AT2 receptor expression of about 5-fold when compared with that in control pancreas 
(Figure 3-35). 
3.4.4 Cellular localization of angiotensinogen in pancreatitis 
The localization of angiotensinogen was studied by inununohistochemistry. The 
results revealed that angiotensinogen was specifically localized in endothelia ofblood 
vessels and epithelia of pancreatic ducts respectively in both normal and pancreatitis 
pancreas. The enhanced unmunoreactivity was found more intense in pancreatitis rat 
when compared with those in normal pancreas. Specificity of the immunostaining 
was validated by the negative control experiments in which no immunostaining was 
observed (Figure 3-36). � 
_ 
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Figure 3-32: (a) RT-PCR analysis of agniotensinogen mRNA in pancreatitis rat. Lane 
M, DNA marker; lane 1，expression in normal rat; lane 2, expression in pancreatitis rat; 
lane 3, p-actin expression in normal rat; lane 4，p-actin expression in pancreatitis rat. The 
arrows indicate the expected size of amplified products from angiotensinogen (312 bp) 
and p-actin (240 bp), (b) The relative expression of agniotensinogen /p_actin mRNA. 
The data are expressed as mean 土 SE. 
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Figure 3-33: (a) RT-PCR analysis of AT,3 mRNA in pancreatitis rat. Lane M, DNA 
marker; lane 1，expression in normal rat; lane 2, expression in pancreatitis rat; lane 3, p-
actin expression in normal rat; lane 4，p-actin expression in pancreatitis rat. The arrows 
indicate the expected size of amplified products from AT,a (385 bp) and p-actin (240 bp), 
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Figure 3-34: (a) RT-PCR analysis of AT,b m R N A in pancreatitis rat. Lane M, DNA 
marker; lane 1, expression in normal rat; lane 2，expression in pancreatitis rat; lane 3，p-
actin expression in normal rat; lane 4，p-actin expression in pancreatitis rat. The arrows 
indicate the expected size of amplified products from AT,b (204 bp) and P-actin (240 bp), 
(b) The relative expression of AT,b /p-actin mRNA. The data are expressed as mean 土 
SE. 
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Control Pancreatitis 
Figure 3-35: (a) RT-PCR analysis of ATj mRNA in pancreatitis rat. Lane M, DNA 
marker; lane 1, expression in normal rat; lane 2，expression in pancreatitis rat; lane 3，P-
actin expression in normal rat; lane 4, p-actin expression in pancreatitis rat. The arrows 
indicate the expected size of amplified products from ATj (511 bp) and p-actin (240 bp), 
(b) The relative expression of ATj/p-actin mRNA. The data are expressed as mean 士 SE. 
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Figure 3-36: CeUular locaHzation of angiotensinogen protein in normal and pancreaitis 
rats, (a) Intense immunoreactivity for angiotensinogen was locaUzed predominantly in the 
endotheUa and in the epitheUal ceUs of blood vessels (BV) and pancreatic ducts (PD) 
respectively in the pancreatitis rat. ¢ ) Less intense immunoreactivity for angiotensinogen 
protein was locaEzed in the pancreatic vasculature and ductal system in the normoxic rat. 
Note: No immunoreactivity was found in the acinar ceUs ofpancreas. (c) The specificity 
of immunostaining was vaUdated by the substitution of primary antibody with buffer. 
96 
Chapter 4 Discussion 
4.1 Existence ofa local RAS in the rat pancreas 
The expression and localization of several key elements of RAS such as renin 
and in particular angiotensinogen, which is the indispensable element for intracellular 
generation of angiotensin II, in the rat pancreas have been studied at the gene and 
protein levels in the present study. RT-PCR results showed that there was mRNA 
expression of angiotensinogen, renin, angiotensin II receptor subtypes ATia, ATib and 
I* AT2 in rat pancreas. Di line with mRNA expression, the precursor angiotensinogen 
r 
protein has also been expressed in the rat pancreas as demonstrated by Westem blot 
analysis. As RT-PCR and Westem blot do not provide precise cellular localization of 
the expression for angiotensinogen, immunohistochemistry was then employed to 
provide topographic information of angiotensinogen expression in the pancreas. � 
hnmunohistochemical results showed that immunoreactivity for both angiotensinogen 
•» 
and renin was specifically localized in the pancreatic ductal epithelia and vascular 
endothelia of the pancreas. Taken together, all these data suggested that the rat 
pancreas possesses the major components of an intrinsic RAS. This is the first study 
to demonstrate the existence of a local RAS in the rat pancreas, with possible 
paracrine or autocrine roles in the regulation of pancreatic microcirculation and ductal 
anion secretion. 
Previous studies have shown angiotensin II and its receptor subtypes, namely 
ATi and AT2, to be localized in the rat pancreas [Leung et al., 1997a; Leung et al., 
1998]. Di those studies, the immunoreactivity for angiotensin II and its receptor 
subtypes ATi and AT2 has been immunohistochemically localized predominantly in 
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the endothelia of the blood vessels and epithelia of pancreatic ductal system. Weak 
unmunoreactivity was also found in smooth muscle cells overlying the blood vessels 
as well as in the pancreatic ducts. The presence of angiotensin II and its receptors in 
the muscle layers overlying the pancreatic blood vessels and the ducts is expected as 
one of the major roles of angiotensin II has classically been known to be a potent 
peptide for muscle contraction [Peach, 1977]. 
It is well known that angiotensin II is a potent vasoconstrictor. Its 
vasoconstrictive effect is due to the increase of muscle contraction by the action on its 
specific receptors located in the vascular smooth muscle. Diterestingly, marked and 
intense immunoreactivity was found in endothelia when compared to that in smooth 
muscle cells. While this may seem somewhat expected, previous reports have shown 
that vasoconstriction evoked by angiotensin II is modulated by the presence of certain 
factors in endothelium in blood vessels of dog and rat pvlanabe et al., 1989; Yen et al., 
1990; Lin and Nasjletti., 1991]. Li addition, high expression of ATi receptors in the � 
vascular endothelium in mammalian tissues has been demonstrated 
immunohistochemically using a monoclonical antibody to the ATi receptors [Barker 
et al., 1993, 1995]. Also, the involvement of angiotensin II through its receptors 
located in endothelimn-mediated vasoconstriction has been demonstrated in rat 
carotid artery [Boulanger et al., 1995]. The previous data together with the present 
data indicate that a local RAS may be important in the regulation of regional blood 
flow in the rat pancreas. 
On the other hand, stimulatory effect of angiotensin II on either Na+ or C1' 
secretion has been demonstrated in a number of exocrine glands, including the 
tracheal epithelium pS[orris et a l , 1991], intestinal epithelium [Cox et al., 1987], renal 
tubular epithelium [Coppola and Fr6mter, 1994] and epididymal epithelium [Wong et 
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al.’ 1990]. ]ta the rat epididymis, inununoreactivity for angiotensin II [Zhao et al., 
1996a] and its receptor subtypes [Leung et al., 1997b，1997c] have recently been 
localized in epididymal epithelial cells, suggesting that a local RAS could play a 
paracrine or autocrine role in regulating anion secretion in the epididymis. This 
notion is further supported by the observed stimulatory effect of angiotensin II on 
anion secretion across the cystic fibrosis pancreatic duct (CFPAC-1) cells [Chan et al., 
1997]. In the present study, immunoreactivity for angiotensinogen and renin have 
been unequivocally localized in epithelia of the pancreatic ducts. Taken together with 
the previous localization of angiotensin II and its receptors, a local RAS is likely to be 
involved in the mediation of the exocrine pancreatic function, such as bicarbonate 
secretion by the pancreatic ducts in the rat pancreas. 
The notion for an intrinsic angiotensin system has been previously suggested in 
canine pancreas based on the local expression of several RAS components expression. 
Using techniques of molecular biology and biochemistry, angiotensinogen mRNA, � 
angiotensinogen protein, angiotensin II and high-affinity binding sites for angiotensin 
II were found in canine pancreas [Chappell et al., 1991].' Later, angiotensin II 
receptor subtypes were also characterized pharmacologically in the dog pancreas 
[Chappell et al., 1992]. Neither angiotensin I nor renin activity were detected in the 
canine pancreas. Dideed, the canine pancreas contains high concentrations of 
kallikrenin [Hojima et al., 1977]. This enzyme is capable of generating angiotensin II 
directly from angiotensinogen [Arakawa et al., 1980b]. It is plausible to suggest that 
an alternative renin-independent pathway for RAS is involved in the canine pancreas. 
The generation of angiotensin II directly from angiotensinogen as suggested in 
canine pancreas is one class of non-renin angiotensinogenases. A second class of 
non-renin angiotensinogenases is the non-renin enzymes capable of cleaving 
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angiotensinogen to angiotensin I. It is also possible that locally-formed 
angiotensinogen is secreted and then processed extracellularly to angiotensin II by 
circulating plasma renal renin. These three alternative models of angiotensin II 
generating systems have previously been proposed for tissues where mRNA for 
angiotensinogen is present but mRNA for renin may, or may not, be expressed [Dzau 
et al., 1986, 1988b]. The biosynthesis pathway of local RAS pathway as observed in 
the rat pancreas seems totally different from that in canine pancreas. Results from the 
present study demonstrated the expression of renin mRNA and the localization of ., 
renin protein in the rat pancreas. It is therefore tempting to propose that a renin-
dependent biosynthetic pathway is more likely to be involved in pancreatic RAS. 
However, further investigations ^ e needed to confirm the renin-dependence and the 
precise site of angiotensin II formation in the rat pancreas. 
In a previous study, it was unable to detect angiotensinogen mRNA by Northern 
blot in the rat pancreas [Campbell and Habener, 1986]. This could be due to limited � 
sensitivity of Northern blot method and also low expression of angiotensinogen 
mRNA in the rat pancreas. This problem was overcome in the present study, by using 
a much higher sensitivity ofRT-PCR. Angiotensinogen mRNA was detected but with 
a low expression level when compared to that in liver and kidney which are known to 
express angiotensinogen mRNA [Phillips et al., 1993]. 
Consistent with the present study in the rat pancreas, a local RAS in human 
pancreas has been recently demonstrated. In that study, the ATi receptor protein and 
prorenin protein as well as its mRNA were localized by immunocytochemistry and in 
situ hybridization respectively. The results have shown the presence of ATi receptor 
and prorenin both in the beta cells of the islets of Langerhans, and in endothelial cells 
of the pancreatic vasculature. Prorenin mRNA was confined to connective tissue 
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surrounding the blood vessels and in reticular fibres within the islets. It is suggested 
that a tissue RAS may be present in human pancreas and it may directly affect beta 
cell function as well as pancreatic blood flow [Tahmasebi et al., 1999]. 
4.2 Regulation of pancreatic RAS by chronic hypoxia 
The existence of a local RAS in the rat pancreas has been consolidated in the 
present study, based on the expression and localization of several major components 
including the precursor angiotensinogen, its enzyme renin and the angiotensin II 
i t receptor subtypes ATi and AT2. It suggested that pancreatic RAS may play a local 
r 
regulation of pancreatic blood flow and ductal secretion in an autocrine or paracrine 
fashion [Leung et al., 1999]. It has been demonstrated that the expression of local 
RAS is subject to the regulation by a number of factors such as hormone and hypoxic 
stress. We therefore aimed the present study at elucidating the regulation of � 
pancreatic RAS expression by chronic hypoxia. 
一 
Results from the present study have demonstrated the activation of several major 
RAS components by chronic hypoxia in both neonatal and mature rat pancreas. 
Chronic hypoxia caused a marked increase in angiotensinogen mRNA and its protein 
expression in both neonatal and mature rat pancreas. However, there was a 
differential mRNA expression change in receptor subtypes for ATia, ATib and AT2. 
hi immature rat pancreas, there was an apparent change in ATib mRNA expression 
but no significant change in ATia mRNA expression. This observation was totally 
reversed in the mature rat, where there was no significant change in ATib mRNA 
expression but an apparent increase in ATia mRNA expression. For AT2 mRNA 
expression, there was a marked increase in both neonatal and mature rat pancreas by 
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chronic hypoxia. These data clearly indicate that chronic hypoxia activates the 
pancreatic RAS via the up-regulation of its components. 
The RAS have been reported to be regulated by many factors, hi one study, ATi 
receptors in astrocytes were up-regulated by growth hormone or insulin-like growth 
factor 1. It was suggested to initiate consequential cardiovascular and angiogenic 
effects [Wyse and Semia., 1997]. The role of estrogen in the regulation of 
angiotensinogen gene, the obUgatory component of RAS, in multiple tissues has also 
been studied. It was found that the regulation of angiotensinogen gene expression by 
estrogen is in a tissue-specific manner. Estrogen up-regulated angiotensinogen 
mRNA in rat liver, aorta and kidney but no significant effect Was observed in cardiac 
atria [Gordon et al., 1992]. Ln addition, a decrease in AT2 receptor binding was found 
in adrenocorticotrophic hormone (ACTH) treatment [Kitamura et al., 1998]. 
In the present study, the regulation of expression of local RAS components by 
chronic hypoxia in rat pancreas has been studied. Previous studies have shown that � 
chronic hypoxia activates the local RAS in a number oftissues such as the renal RAS 
PSfeylon et al., 1996; Fletcher et al., 1999], lung RAS [Morrell et al., 1995a，1995b; 
Zhao et al., 1996b] and cardiac RAS [Morrell et aL, 1997]. These indicated that the 
up-regulation of RAS components by chronic hypoxia may be important in the 
regulation of physiology and pathophysiology of these tissue functions. 
The current study is the first to present data on the activation of local RAS by 
chronic hypoxia in the rat pancreas. The up-regulated expression of angiotensinogen 
and angiotensin receptors may imply that there was an increase in the production of 
physiologically active angiotensin II. As angiotensinogen is the sole precursor for 
RAS, angiotensin II produced from the pancreas may enhance its action via the 
mediation of angiotensin receptors. The significant up-regulation of angiotensinogen 
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and angiotensin receptors in the rat pancreas may be responsible for fmely regulating 
the physiological and pathophysiological aspects of the pancreas during chronic 
hypoxia. RAS is well documented for its vasoconstrictive and physiological effects 
on the cell hypertrophy or hyperplasia and stimulation of hormone secretion and ion 
transport [Peach, 1977]. It has also demonstrated that angiotensin II receptors 
influence the prostagladin synthesis [Jaiswal et aL, 1990，1991] which in tum may 
mediate the secretion ofinsulin and glucagon [Kelly and Laychock, 1981]. 
In the present study, it is interesting to show that there was a differential change 
in the expression of ATi receptor by chronic hypoxia. ATi was reported to be the 
main receptor for angiotensin II to exert diverse actions on the target tissues such as 
controlling vascular tone, hormone secretion, tissue growth and neuronal activities 
[Kakar et al., 1992b]. One study also suggested that AT! receptor has been inferred to 
the clearance of angiotensin II through the mechanism of receptor internalization 
[Anderson et al., 1993; Iyer et al., 1998]. In neonatal rat, the increase in expression is � 
mainly on ATib receptor but no significant change in ATia receptor. However, there 
was activation of ATia receptor expression but no significant Change in ATib receptor 
expression in mature rat. This receptor subtype specific change has also been 
observed in adrenal RAS in response to hormonal treatment (ACTH) in which there 
was a decrease of the ATib subtype mRNA, in contrast to the unchanged ATia mRNA 
expression [Kitamura et al., 1998]. In addition, it shows an increase in ATib receptor 
mRNA expression while an decrease in ATia mRNA expression by a low salt intake 
[Du et al., 1995; Schmid et al., 1997]. 
bi the case of the ATi receptor, two closely related subtypes have been 
demonstrated in the mouse and rat [Iwai and biagami, 1992; Dzau et al., 1993]. A 
study has reported small differences in binding characteristics between the ATia and 
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ATib receptors when expressed in adrenal Y-1 cells [Tian et al., 1996]. Actually, both 
ATia and ATib receptor subtypes share 96% sequence homology at the nucleotide 
levels [Lewis et al., 1993]. However, it is unclear whether there are functional 
differences in the physiological role of these receptor subtypes. Some reports 
supported the notion that the presence of the two ATi receptor subtypes may allow 
greater flexibility of regulation of ATi receptor subtype expression [Du et al., 1995; 
Schmid et al., 1997]. 
The differential responses on ATi receptor in both neonatal and mature rats by 
chronic hypoxia may reflect a developmental change of pancreatic RAS expression 
during growth. This age-dependent effect on RAS by chronia hypoxia has also been 
proposed from the previous study. In that study, two groups of rats aged 2 and 30 
days were employed for chronic hypoxia. It was found that the urine output, water 
intake and right ventricular hypertrophy were numerically greater in neonates. Lung 
ACE activity was also decreased in altitude-exposed neonates. These data indicated � 
that the degree and, in some cases, the nature of these homeostatic responses vary 
with age during long-term hypoxia [Jain et al., 1990]. ‘ 
For the expression change of another angiotensin receptor AT2, a marked 
increase in expression in both neonatal and mature rat were found. Nevertheless, the 
actual physiological role of this receptor remains controversial, bi a study on the 
binding sites of angiotensin II in canine pancreas, AT2 receptor was proposed to be 
the majority of angiotensin II receptors by receptor binding study and by 
autoradiographic study. The binding sites are localized over islet cells, acinar and 
ductal cells, as well as pancreatic vasculature [Chappell et al., 1991]. It has been 
suggested that AT2 receptor may antagonize the effects of ATi receptor on blood 
pressure elevation [Hein et al., 1995]. It has also been suggested that AT2 receptor is 
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involved in the control of apoptosis, a form of programmed cell death [Yamada et al., 
1996]. However, the role of AT2 receptor in the pancreas and its up-regulation during 
chronic hypoxia still remains to be elucidated. 
All the data have shown that chronic hypoxia can activate the pancreatic RAS 
particularly at the level of angiotensinogen and AT2 receptor. The up-regulation of 
local RAS may be responsible for the physiological adaptation during chronic 
hypoxia. However, it is also possible that chronic hypoxia could lead to 
pathophysiological change of the tissues such as induction of hypoxia-induced 
pancreatic injury. It is therefore interesting to further examine whether the change of 
RAS in response to chronic hypoxia could be reversible after a defmite period of 
normoxic recovery. >  
After chronically hypoxic exposure as mentioned, adult rats were placed back 
for normoxic recovery for 1 week, 2 weeks, 3 weeks and 4 weeks respectively. The 
reversibility pattem of RAS component, in particular reference to the AT2 receptor � 
expression, was determined by a standard-curve, QC-RT-PCR technique. This 
method provides an absolute quantitation of AT2 receptor mRNA expression in a 
defmite period during recovery. The recovery pattem of AT2 receptor was selected 
for investigation because there was a marked significant increase in the mRNA 
expression for AT2 receptor after chronic hypoxia. It appears that AT2 receptor could 
play an important role in the physiological and possible pathophysiological changes 
of pancreatic functions during prolonged oxygen deprivation. Results from the 
present recovery study showed that the increased expression of AT2 receptor by 
chronic hypoxia could be reversible at about 2 weeks. This implies that the up-
regulation of pancreatic RAS components in particular reference to AT2 receptor may 
be recoverable, after returning to the normoxic condition for about a period of 2 
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weeks onwards. This observation may be also in agreement with the chronic hypoxic 
model in which the animals were kept in maximal exposure ofhypoxic stress without 
the ftill development of pathophysiological events that would impact the vitality of the 
animals. Interestingly, a similar study on the expression change of angiotensin 
receptors during chronic hypoxic treatment has also been demonstrated in the RAS of 
the lung. A differential effect on ATi and AT2 receptor were found in that study 
[Chassagne et al., 2000]. However, the significance in the changes of AT2 receptor 
expression during chronic hypoxia and its degree of reversibility after returning to 
normoxic needs fiu:ther investigation. 
i t 
r 
4.3 Regulation of pancreatic RAS by pancreatitis 
In the study of expression change of pancreatic RAS by chronic hypoxia, an 
activation ofmajor RAS components notably angiotensinogen and AT2 receptor were � 
unequivocally demonstrated. The activation of an intrinsic RAS in response to 
一 
chronically hypoxic stress may therefore be responsible for the physiological and 
pathophysiological aspects of the pancreas, hi fact, the association between the 
activation of plasma renin and its clinical relevance to pancreatic injury such as acute 
pancreatitis has been reported [Greenstein et al., 1987]. It has also been shown that 
angiotensin II-mediated selective pancreatic vasoconstriction results in significant 
pancreatic ischemia during exposure to stress such as cardiogenic shock [Reilly et al., 
1997]. Taken together, it is therefore plausible to suggest that activation ofpancreatic 
RAS during chronicaUy hypoxic stress may lead to hypoxia-induced pancreatic 
injury. Hence, the significance of regulated expression of pancreatic RAS using a rat 
model of experimental pancreatitis was targeted for further investigation in the 
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present study. 
In the present study, the regulation and expression of pancreatic RAS in 
experimentally induced acute pancreatitis of the rat have been elucidated at the gene 
and protein levels using Westem blot, RT-PCR and immunohistochemical 
approaches. The data demonstrated unequivocally that experimental pancreatitis 
elicited the up-regulation of several key RAS components in the pancreas. 
Pancreatitis markedly increased the expression of angiotensinogen both at the 
protein and gene levels, as evidenced by inununoblotting and RT-PCR. hi parallel 
with these expression levels, immunohistochemical results further demonstrated that 
the enhanced immunoreactivity for angiotensinogen in pancreatitis was predominantly 
localized to endothelia and epithelia of blood vessels and pancreatic ducts 
respectively, when compared with those in normal pancreas. 
In addition to angiotensinogen, expression change of angiotensin receptors have 
also been studied. Pancreatitis caused a markedly increased in AT2 receptor � 
expression. For ATi receptor, pancreatitis caused, however, a significant change in 
mRNA expression for ATia subtype whereas no marked effect on mRNA expression 
for ATib subtype, as demonstrated by RT-PCR using primers specific for the 
respective 3'-noncoding sequences of ATu and ATib receptor subtypes. The data 
clearly indicate that pancreatitis could activate the local RAS in the pancreas, notably 
at the level of its components, angiotensinogen and AT2 receptor. 
It has been known that prolonged hypoxia causes decreased blood flow to the 
tissues, which may in tum lead to tissue inflammation and injury. For example, 
alcohol was blamed to induce hypoxia in the pancreas, which could provide 
mechanism for pancreatic injury such as pancreatitis [Foitzik et al., 1995]. hi cats, 
ethanol reduced pancreatic blood flow by 62%. Whilst, in cats with pancreatitis basal 
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pancreatic blood flow was only 60% of the normal flow [Toyama et al., 1997]. The 
pathogenesis of alcoholic pancreatitis is not folly defmed. The ultimate picture is 
tissue autolysis by activated proteolysis enzymes. The triggers for such activation, 
however, are not still not known [Schenker and Montalvo, 1998]. Alcohol may affect 
the integrity of the pancreatic parenchyma, as well as loss ofdifFerentiative features of 
acinar cells. Sustained alcohol intake may induce the accumulation of lipid droplets 
in parenchymal cells, some of which may be shown to be within the rough 
endoplasmic reticulum of acinar cells. Also, alcohol causes the deposition of protein 
in peripheral ducts leading to obstruction , inflammation and degeneration of pancreas 
n^Joronha et al., 1981; Wilson and Pirola, 1983; Bockman et aL, 1985]. 
The present study is the first to elaborate the effect of experimentally induced 
acute pancreatitis on the regulated expression of local RAS in the rat pancreas. The 
up-regulation of pancreatic angiotensinogen was particularly striking both at the gene 
and protein levels and enhanced expression of angiotensinogen was localized by � 
inununohistochemistry to the endothelia and epithelia of the blood vessels and 
pancreatic ducts respectively. The data appear to suggest that the activation of 
pancreatic angiotensinogen may play a role in the induction of pancreatic injury. 
Previous reports have shown that there was an induction of plasma angiotensinogen 
following acute inflammation, indicating the potential importance of angiotensinogen 
in the regulation of local inflammatory responses and tissue injury [Kageyama et al., 
1985; Okamoto et al., 1987; Gomez et al., 1993]. Interestingly, angiotensinogen 
protein was previously identified as a member of proteins designated as ‘acute 
phase reactants'. This may be accountable for the induction of angiotensinogen in 
response to inflammatory response [Koji, 1974]. hi addition, angiotensinogen is the 
protein resulting from acute-phase response which is a protective physiological 
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reaction to tissue injury in order to re-establish the homeostasis altered by injury [Ron 
et al., 1990]. In fact, the activation of angiotensinogen expression during tissue injury 
has been demonstrated in a number of tissues including the kidney [Suzuki et al., 
1998; Ruiz-Ortega et al., 1998]，the heart [Ogiku et aL, 1996] and the vasculature 
[Rakugi et al., 1993]. 
On the other hand, the present study demonstrated that pancreatitis markedly and 
significantly increased the expression of AT2 receptor. As described previously, AT2 
receptor is suggested to be involved in the control ofapoptosis [Yamada et al., 1996]. 
Form a more recent study, inflammation was found to influence vascular remodeling 
through the mediation of AT2 receptor expression and signaling. The AT2 receptor, 
which exerts growth inhibitory effects in cell culture, is present scantily in the adult 
vasculature but is re-expressed after vascular injury [Akishita et al., 2000]. The AT： 
receptor was found to inhibit proliferation and promote cell differentiation. The AT2 
receptor stimulates vasodilatation and natriuresis by an autocrine cascade including � 
bradykinin, nitric oxide and cyclic GMP. The AT2 receptor has been also found to 
control vasodilator prostaglandin, which plays a role for blbod pressure regulation. 
The AT2 receptor appears to play a counter-regulatory protective role in the regulation 
of blood pressure and sodium excretion that opposes the role for ATi receptor [Carey 
et al., 2000; Matsubara, 1998]. 
One more interesting finding in this study is that the ATi receptor showed a 
similar expression change pattem both in pancreatitis rat and in chronically hypoxic 
mature rat. The ATia receptor subtype showed an apparent increase in expression 
while no significant change in that of ATib receptor subtypes. Taken together, it is 
possible to speculate that the up-regulation of AT2 receptor rather than ATi receptor 
and the activation of locally expressed angiotensinogen in the pancreas could have a 
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more prominent role in the regulation of physiology and possible pathophysiology of 
pancreatitis. However, the association between activation of pancreatic RAS and 
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4.4 Conclusion 
There are currently few and certainly no conclusive descriptions of the 
pancreatic RAS and its functions. The results of the present study should establish a 
link between pancreatic exocrine functions and RAS in the pancreas. The present 
study has shown: 
I . The existence of an intrinsic RAS in the rat pancreas. ‘ 
I I . That pancreatic RAS is activated by chronic hypoxia. 
I I I . That activation of pancreatic RAS by chronic hypoxia is reversible. 
IV. The activation of pancreatic RAS is also subject to the activation in 
experimentally induced pancreatitis. “ 
The changes of pancreatic RAS in response to chronic hypoxia and pancreatitis 
and their effects on locally regulating the pancreatic blood flow and ductal anion 
secretion in response to chronic hypoxia may be responsible for the physiological 
adaptation, which could trigger the pathophysiological events of pancreatic injury � 
such as pancreatitis. The significance of the present results on the pancreatic RAS 
»* 
may have clinical relevance to hypoxia-induced pancreatic injury. 
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4.5 Further work 
ki the present study, the mRNA expression of major components for RAS has 
been demonstrated by RT-PCR. In addition, the protein expression of 
angiotensinogen and renin protein has also been localized by immunohistochemistry. 
The next immediate work is to study the detailed expression and localization of 
angiotensinogen and renin in the pancreas by in situ hybridization histochemistry as a 
tool. Jn addition, the following is some of the suggested work in the future. 
Roles of pancreatic RAS 
As the existence of an intrinsic pancreatic RAS has been confirmed in the 
pancreas, its functional role on pancreas is the next interesting issue to deal with for 
our further study, hi order to achieve this goal, the effects of angiotensin II and the 
actions of its specific antagonists for the receptors ATi and AT2 on the pancreatic 
blood flow should be studied by in vivo microcirculation microscopy technique. To � 
this end, the role of pancreatic RAS in regulating the pancreatic microcirculation will 
be elucidated. 
Recovery study on the regulated expression of pancreatic RAS by chronic hypoxia 
The reversibility of AT2 receptor expression in recovery study has been studied 
in this study. The recovery study on other up-regulated RAS components, especially 
angiotensinogen, which exhibited a significant up-regulation after chronic hypoxia, 
should be the next component for studying. Moreover, the recovery profile of RAS 
between neonatal and mature rats could be worked out in order for providing useful 
information of its effects on the developmental changes ofthe rats. 
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The association between pancreatic RAS and its regulated expression by chronic 
hypoxia and acute pancreatitis 
For the present results, it appeared that both chronic hypoxia and acute 
pancreatitis could activate the pancreatic RAS. There was a marked up-regulation of 
expression for angiotensinogen and AT2 in chronic hypoxia and experimental 
pancreatitis. It is therefore of special interest in fmding out whether chronic hypoxia 
could lead to hypoxia-induced injury such as acute pancreatitis. In this regard, 
pancreatitis associated protein, which was reported to highly express in acute 
pancreatitis, may be employed as a useful tool for a marker for the detection of acute 
pancreatitis. The expression pattem of this protein in chronic hypoxia and its 
association with hypoxia-induced pancreatic injury could then be studied as to 
provide some preliminary information to this end. 
� 
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